<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" id="cre270121" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Clin Exp Dent Res</journal-id><journal-id journal-id-type="iso-abbrev">Clin Exp Dent Res</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)2057-4347</journal-id><journal-id journal-id-type="publisher-id">CRE2</journal-id><journal-title-group><journal-title>Clinical and Experimental Dental Research</journal-title></journal-title-group><issn pub-type="epub">2057-4347</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40410949</article-id><article-id pub-id-type="pmc">PMC12102072</article-id><article-id pub-id-type="doi">10.1002/cre2.70121</article-id><article-id pub-id-type="publisher-id">CRE270121</article-id><article-categories><subj-group subj-group-type="overline"><subject>Original Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Medication Purchases Are Associated With the Number of Dental Treatments</article-title></title-group><contrib-group><contrib id="cre270121-cr-0001" contrib-type="author" corresp="yes"><name><surname>Frankenhaeuser</surname><given-names>Freja</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-2431-6590</contrib-id><xref rid="cre270121-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>Freja.frankenhaeuser@helsinki.fi</email></address></contrib><contrib id="cre270121-cr-0002" contrib-type="author"><name><surname>K&#x000e4;llm&#x000e9;n</surname><given-names>H&#x000e5;kan</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-9288-3864</contrib-id><xref rid="cre270121-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="cre270121-cr-0003" contrib-type="author"><name><surname>Meurman</surname><given-names>Jukka</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-6702-6836</contrib-id><xref rid="cre270121-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="cre270121-cr-0004" contrib-type="author"><name><surname>Korpi</surname><given-names>Esa</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-0683-4009</contrib-id><xref rid="cre270121-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="cre270121-cr-0005" contrib-type="author"><name><surname>S&#x000f6;der</surname><given-names>Birgitta</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-5656-9210</contrib-id><xref rid="cre270121-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib></contrib-group><aff id="cre270121-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Department of Oral and Maxillofacial Diseases</named-content>
<institution>University of Helsinki</institution>
<named-content content-type="country-part">Helsinki</named-content>
<country country="FI">Finland</country>
</aff><aff id="cre270121-aff-0002">
<label>
<sup>2</sup>
</label>
<institution>Uppsala University</institution>
<city>Uppsala</city>
<country country="SE">Sweden</country>
</aff><aff id="cre270121-aff-0003">
<label>
<sup>3</sup>
</label>
<institution>Department of Pharmacology</institution>
<city>University of Helsinki</city>
<named-content content-type="country-part">Helsinki</named-content>
<country country="FI">Finland</country>
</aff><aff id="cre270121-aff-0004">
<label>
<sup>4</sup>
</label>
<named-content content-type="organisation-division">Department of Dental Medicine</named-content>
<institution>Karolinska Institutet</institution>
<city>Solna</city>
<country country="SE">Sweden</country>
</aff><author-notes><corresp id="correspondenceTo">
<label>*</label>
<bold>Correspondence:</bold> Freja Frankenhaeuser (<email>Freja.frankenhaeuser@helsinki.fi</email>)<break/>
</corresp></author-notes><pub-date pub-type="epub"><day>23</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>6</month><year>2025</year></pub-date><volume>11</volume><issue seq="20">3</issue><issue-id pub-id-type="doi">10.1002/cre2.v11.3</issue-id><elocation-id>e70121</elocation-id><history>
<date date-type="rev-recd"><day>07</day><month>3</month><year>2025</year></date>
<date date-type="received"><day>19</day><month>12</month><year>2024</year></date>
<date date-type="accepted"><day>19</day><month>3</month><year>2025</year></date>
</history><permissions><!--&#x000a9; 2025 The Author(s). Clinical and Experimental Dental Research published by John Wiley & Sons Ltd.--><copyright-statement content-type="article-copyright">&#x000a9; 2025 The Author(s). <italic toggle="yes">Clinical and Experimental Dental Research</italic> published by John Wiley &#x00026; Sons Ltd.</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:CRE2-11-e70121.pdf"/><abstract><title>ABSTRACT</title><sec id="cre270121-sec-0010"><title>Objectives</title><p>Little is known whether the number of systemic medications, indicating worsened general health, affects the number of dental appointments needed. The hypothesis is that patients purchasing more systemic medications would have an increased number of dental appointments and respective need for treatments than patients who do not purchase as many medications.</p></sec><sec id="cre270121-sec-0020"><title>Materials and Methods</title><p>Our cohort consists of 1495 participants from the Stockholm area, Sweden, initially examined in 1985. Using national population and patient registers (2005&#x02013;2017), the association between the number of medication purchases and dental appointments was analyzed. The Anatomical Therapeutic Chemical Classification System for Medicines (ATC) was used. Descriptive statistics, chi&#x02010;square tests, and logistic regressions were used with several covariates like gender and socioeconomic status.</p></sec><sec id="cre270121-sec-0030"><title>Results</title><p>Purchases above the median of all medications showed a statistically significant association with more dental appointments and respective treatments. Most of the ATC system's main drug categories were significantly associated with more dental appointments, even when adjusting for covariates. Purchases of medications from 32 different ATC subgroups were significantly associated with the number of dental appointments above the median.</p></sec><sec id="cre270121-sec-0040"><title>Conclusion</title><p>In the group of adult Swedes who were studied, it was found that increased purchasing of nearly all types of drugs was associated with an increased number of dental appointments between the study years 2005&#x02013;2017.</p></sec></abstract><kwd-group><kwd id="cre270121-kwd-0001">dental appointments</kwd><kwd id="cre270121-kwd-0002">hyposalivation</kwd><kwd id="cre270121-kwd-0003">medication purchase</kwd><kwd id="cre270121-kwd-0004">polypharmacy</kwd><kwd id="cre270121-kwd-0005">xerostomia</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source>This study was supported by the Swedish Ministry of Health and Social Affairs (grants F84/189), Karolinska Institutet, and King Gustav V&#x000b4;s and Queen Victoria Freemason&#x000b4;s Foundation, Sweden. Other grants have been received from The Finnish Society of Sciences and Letters, The Finnish Medical Society, and Odontologiska Samfundet, Finland.</funding-source></award-group></funding-group><counts><fig-count count="1"/><table-count count="6"/><page-count count="10"/><word-count count="6261"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>June 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.6 mode:remove_FC converted:24.05.2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="cre270121-sec-0050"><label>1</label><title>Introduction</title><p>Multimorbidity, simultaneously having two or more chronic systemic conditions, is expected to rise as the population ages (WHO&#x000a0;<xref rid="cre270121-bib-0036" ref-type="bibr">2007</xref>). Multimorbidity is associated with decreased quality of life, higher healthcare costs, and a higher risk of mortality (Makovski et al.&#x000a0;<xref rid="cre270121-bib-0017" ref-type="bibr">2019</xref>; Tooth et al.&#x000a0;<xref rid="cre270121-bib-0032" ref-type="bibr">2008</xref>). Importantly, systemic diseases and oral health are closely connected (Tavares et al.&#x000a0;<xref rid="cre270121-bib-0029" ref-type="bibr">2014</xref>). Polypharmacy, a long&#x02010;term use of more than five different medications, is also an emerging problem (Masnoon et al.&#x000a0;<xref rid="cre270121-bib-0018" ref-type="bibr">2017</xref>), which is associated with reduced saliva secretion and dry mouth (Johanson et al.&#x000a0;<xref rid="cre270121-bib-0013" ref-type="bibr">2015</xref>; Villa and Abati&#x000a0;<xref rid="cre270121-bib-0034" ref-type="bibr">2011</xref>). Polypharmacy and multimorbidity are often seen in the same patients, where also a risk appears for drug&#x02010;drug and drug&#x02010;disease interactions (Daunt et al.&#x000a0;<xref rid="cre270121-bib-0005" ref-type="bibr">2023</xref>).</p><p>Globally, 3.5 billion people suffer from oral diseases, them being the most prevalent health problem with 2 billion untreated caries lesions and 1 billion severe periodontal disease cases (Jain et al.&#x000a0;<xref rid="cre270121-bib-0012" ref-type="bibr">2024</xref>). Gingivitis, periodontitis, and periapical periodontitis are diseases associated with systemic health (Noites et al.&#x000a0;<xref rid="cre270121-bib-0022" ref-type="bibr">2022</xref>; Sebring et al.&#x000a0;<xref rid="cre270121-bib-0024" ref-type="bibr">2022</xref>; Herrera et al.&#x000a0;<xref rid="cre270121-bib-0008" ref-type="bibr">2023</xref>). Dental caries and periodontal diseases tend to accumulate in the same subjects and the same teeth (Stangvaltaite&#x02010;Mouhat et al.&#x000a0;<xref rid="cre270121-bib-0028" ref-type="bibr">2024</xref>; Mattila et al.&#x000a0;<xref rid="cre270121-bib-0019" ref-type="bibr">2010</xref>). Common denominators are the lack of oral hygiene, hyposalivation, and altered saliva secretion and their combinations. Dry mouth, an umbrella term for hyposalivation, reduced saliva secretion, low salivary flow rate, salivary gland hypofunction, and xerostomia (the term for the subjective feeling of dry mouth), are caused by hundreds of medications, psychological factors, radiation to the head and neck, as well as by systemic diseases, such as Sj&#x000f6;gren's syndrome and diabetes (Ito et al.&#x000a0;<xref rid="cre270121-bib-0011" ref-type="bibr">2023</xref>). Hyposalivation and xerostomia can lead to decreased quality of life, impair chewing capacity, increase the risk of caries, tooth loss, candidiasis, and decrease overall well&#x02010;being (Barbe&#x000a0;<xref rid="cre270121-bib-0001" ref-type="bibr">2018</xref>; Turner&#x000a0;<xref rid="cre270121-bib-0033" ref-type="bibr">2016</xref>). In particular, hyposalivation and xerostomia are closely connected to the use of many systemic medications, such as anticholinergics, antidepressants, antihistamines, antihypertensive, and antipsychotics (Villa et al.&#x000a0;<xref rid="cre270121-bib-0035" ref-type="bibr">2016</xref>).</p><p>With the background above, our aim of the present register study was to assess the association between the number of purchasing of systemic medications and the risk of an elevated need for more dental appointments with subsequent treatments. Our hypothesis was that patients who purchased many medicines also had worse oral health, thus having more treatment needs when compared with the patients who needed fewer systemic medications.</p></sec><sec sec-type="materials-and-methods" id="cre270121-sec-0060"><label>2</label><title>Materials and Methods</title><p>The participants of the study stem from an original cohort of 105,798 individuals from the metropolitan Stockholm area, Sweden. Out of the cohort, 3273 participants were randomly selected from the individuals born the 20th day of each month and born in the years 1945&#x02010;1954 (S&#x000f6;der et al.&#x000a0;<xref rid="cre270121-bib-0027" ref-type="bibr">1994</xref>). In 1985, 1676 patients out of the 3273 selected patients were clinically examined at baseline. Out of the 1676 patients, a dropout of 21 patients resulted in 1655 participants. Another 160 patients were deceased before 2017 and were excluded from the analyses, resulting in 1495 patients in the present study in 2024 (Figure&#x000a0;<xref rid="cre270121-fig-0001" ref-type="fig">1</xref>). At the time of the current study, the participants were aged 50&#x02013;73 years.</p><fig position="float" fig-type="Figure" id="cre270121-fig-0001"><label>Figure 1</label><caption><p>Flowchart of the present study, inclusion, and exclusion of patients, and the registers used.</p></caption><graphic xlink:href="CRE2-11-e70121-g001" position="anchor" id="jats-graphic-1"/></fig><p>The pharmacology database of the Swedish National Prescribed Drug register spans from the years 2005 to 2017, as used in the present investigation. The register includes all the medications purchased among the 1434 patients here included (Figure&#x000a0;<xref rid="cre270121-fig-0001" ref-type="fig">1</xref>). 61 patients did not purchase any medications. The register consists of the participants&#x000b4; total purchases of medications at Swedish pharmacies, excluding medical supplies and extempore medications. In total 469,789 purchases had been registered. For analyses, the medications were classified according to the Anatomical Therapeutic Chemical classification system (ATC) first in the main groups (the first anatomical level of ATC groups), and, secondly, in the subgroups (the 2nd level of the ATC groups). The ATC contains 14 main groups but in this study 13 of them were included. The ATC group &#x0201c;Various&#x0201d; (code V) was excluded due to its heterogeny and because of too few purchases recorded. Dichotomized variables were coded so that patients purchasing more medications than the median were coded as 1 (=&#x02009;high) and those with median or fewer purchases were coded as 0 (=&#x02009;low).</p><p>The dental health register used for the study is maintained by The National Board of Health and Welfare (Socialstyrelsen<italic toggle="yes">)</italic>, Sweden, and it contains data from the years 2008&#x02013;2017. Included in the register are the date of the appointment, permit code for diagnosis, and code for treatments given at an appointment.</p><p>Different variables for dental treatments were created using The National Board of Health and Welfare's code for treatments. The different variables included dental exams, radiographs, saliva tests, codes for biopsy and laboratory, caries prophylaxis treatments, periodontitis treatments, extractions, endodontic treatments, dental fillings, and complete dentures. All variables were created by summarizing the number of specific treatment codes for each patient and then dichotomized based on treatments below or equal to the median (code 0&#x02009;=&#x02009;low) or above the median (code 1&#x02009;=&#x02009;high). A variable for the total number of dental appointments was created by summarizing the total number of dental appointments for each patient. In conformity with the summation of treatments being above the median (high&#x02009;=&#x02009;1) or below or equal to the median (low&#x02009;=&#x02009;0) another dichotomized variable was then created. Dental diagnoses from the register were deemed too imprecise and thus excluded from the present study. This was due to the large number of different dental providers included in the registry.</p><p>In 1985, the periodontitis diagnosis was based on the existence of at least three PD values of&#x02009;&#x02265;&#x02009;5&#x02009;mm in three different nonadjacent teeth. At the clinical examinations, periodontal pocket probing depths (PD) were measured at six sites per tooth, rounded to the nearest millimeter (S&#x000f6;der et al.&#x000a0;<xref rid="cre270121-bib-0027" ref-type="bibr">1994</xref>). Furthermore, at baseline in 1985, the patients were divided into higher or lower socioeconomic classes based on income and level of education. Patients with a lower level of education and low or no income were coded as having lower socioeconomic status (Code 1), and the ones with greater income and a higher level of education were coded as high (Code 0). In the course of the follow&#x02010;up of the original cohort, a change had been made in Sweden in the way the higher income was officially reported. Consequently, a reliable follow&#x02010;up variable of the socioeconomic status of our participants could not be calculated from the 2017 socioeconomical register of the National Board of Health and Welfare.</p><p>The socioeconomic status parameter, at baseline, was used as a covariate in this study to analyze how socioeconomic status could affect oral health. In 1985, there was no significant difference between the genders of participants with lower socioeconomic status (women <italic toggle="yes">n</italic>&#x02009;=&#x02009;137, 17.9%, men 155, 20.3%). Since both oral health and usage of medications have been shown to differ between genders, a covariate for gender was created, where women were coded as 0 and men as 1. There were 730 men (48.8%) and 765 women (51.2%) among the 1495 participants.</p><p>The patients&#x000b4; usage of tobacco products, smoking or using Swedish snus, was registered at baseline in 1985. A dichotomized tobacco consumption variable was created. Patients who used tobacco products were coded as 1 and those not using tobacco products were coded as 0.</p><p>Visual Studio Code 2, Python 3.9.10 64&#x02010;bit was used for data reorganization, summation of the registers, and calculations. For the descriptive statistics, the genders and their basic characteristics were compared by frequencies, <italic toggle="yes">t</italic>&#x02010;tests, and Chi&#x02010;square tests. A significance was set at 0.05. For medication purchases and dental appointments, the mean, standard deviation (SD), and median were calculated using frequencies. To assess the differences between high and low medication purchasers regarding the number of dental appointments Chi&#x02010;square tests were employed. Medication purchases for the main ATC groups (1st level) and the ATC subgroups (2nd level), respectively, versus high and low dental appointments were analyzed. To eliminate error due to confounders, logistic regression analyses were then conducted with covariables such as gender, tobacco usage, socioeconomic status at baseline in 1985, and further, if the participants had a hospital diagnosis before 1985 (excluding trauma and childbirth). The statistical analyses were conducted in SPSS 28.0 software.</p><sec id="cre270121-sec-0070"><label>2.1</label><title>Ethical Approval</title><p>The Ethics Committee of the Karolinska University Hospital at Huddinge had approved the study (Dnr 2007/1669&#x02013;31; 2012/590&#x02013;32; 2017/2204&#x02013;32).</p></sec></sec><sec sec-type="results" id="cre270121-sec-0080"><label>3</label><title>Results</title><p>In this study, between the years 2005&#x02013;2017, of the participants 93.9% purchased at least one or more systemic medications, while 4.1% did not. The basic characteristics are given in Table&#x000a0;<xref rid="cre270121-tbl-0001" ref-type="table">1</xref>. Women purchased significantly more medications than men and were also significantly more likely to have a hospital diagnosis before 1985. Significantly more men than women had periodontitis at baseline, but no significant difference in tobacco use between the genders was recorded.</p><table-wrap position="float" id="cre270121-tbl-0001" content-type="Table"><label>Table 1</label><caption><p>Basic characteristics of the participants.</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="left" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="center" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="center" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="center" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="center" span="1"/><thead valign="bottom"><tr valign="bottom" style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Characteristics</th><th align="center" valign="bottom" rowspan="1" colspan="1">Total</th><th align="center" valign="bottom" rowspan="1" colspan="1">Women</th><th align="center" valign="bottom" rowspan="1" colspan="1">Men</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic> value</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Participants</td><td align="center" valign="top" rowspan="1" colspan="1">1495 (100%)</td><td align="center" valign="top" rowspan="1" colspan="1">765 (51.2%)</td><td align="center" valign="top" rowspan="1" colspan="1">730 (48.8%)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Medication purchases above the median</td><td align="center" valign="top" rowspan="1" colspan="1">735 (100%)</td><td align="center" valign="top" rowspan="1" colspan="1">421 (57.3%)<xref rid="cre270121-tbl1-note-0001" ref-type="table-fn">a</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">314 (42.7%)<xref rid="cre270121-tbl1-note-0001" ref-type="table-fn">a</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Dental appointments above the median</td><td align="center" valign="top" rowspan="1" colspan="1">755 (100%)</td><td align="center" valign="top" rowspan="1" colspan="1">400 (53.6%)<xref rid="cre270121-tbl1-note-0001" ref-type="table-fn">a</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">355 (46.4%)<xref rid="cre270121-tbl1-note-0001" ref-type="table-fn">a</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.157</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Tobacco consumption in 1985</td><td align="center" valign="top" rowspan="1" colspan="1">518 (100%)</td><td align="center" valign="top" rowspan="1" colspan="1">271 (52.3%)<xref rid="cre270121-tbl1-note-0001" ref-type="table-fn">a</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">247 (47.7%)<xref rid="cre270121-tbl1-note-0001" ref-type="table-fn">a</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.519</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Hospital diagnosis before 1985</td><td align="center" valign="top" rowspan="1" colspan="1">519 (100%)</td><td align="center" valign="top" rowspan="1" colspan="1">319 (61.5%)<xref rid="cre270121-tbl1-note-0001" ref-type="table-fn">a</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">200 (38.5%)<xref rid="cre270121-tbl1-note-0001" ref-type="table-fn">a</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Periodontitis in 1985</td><td align="center" valign="top" rowspan="1" colspan="1">243 (100%)</td><td align="center" valign="top" rowspan="1" colspan="1">107 (44.0%)<xref rid="cre270121-tbl1-note-0001" ref-type="table-fn">a</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">136 (46.0%)<xref rid="cre270121-tbl1-note-0001" ref-type="table-fn">a</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.015</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Lower socioeconomic status in 1985</td><td align="center" valign="top" rowspan="1" colspan="1">292 (100%)</td><td align="center" valign="top" rowspan="1" colspan="1">117 (40.1%)<xref rid="cre270121-tbl1-note-0001" ref-type="table-fn">a</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">155 (59.9%)<xref rid="cre270121-tbl1-note-0001" ref-type="table-fn">a</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.105</td></tr></tbody></table><table-wrap-foot><fn id="cre270121-tbl1-note-0001"><label>
<sup>a</sup>
</label><p>Number of participants and percentages within the given row.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap><p>Table&#x000a0;<xref rid="cre270121-tbl-0002" ref-type="table">2</xref> gives details of the dental appointments, treatments, and medication purchases registered. Between the years 2008 and 2017, 92.2% of our participants attended at least one dental appointment. The most common reasons for dental appointments and respective treatments were dental examinations and placing fillings. As to the purchase of medications, 95.9% did purchase at least one medication. The median of all medication purchases during the time of observation was 85, equivalent to 6.5 medication purchases a year. In the 12 years of the pharmacy register follow&#x02010;up from 2005 to 2017, 90.4% of our patients had purchased different medications from more than one ATC subgroup. The most purchased ATC main groups and subgroups of medications are also given in Table&#x000a0;<xref rid="cre270121-tbl-0002" ref-type="table">2</xref>. The median for all the other subgroups not reported here was 0 (see Attachment&#x000a0;<xref rid="cre270121-suppl-0001" ref-type="supplementary-material">S1</xref>).</p><table-wrap position="float" id="cre270121-tbl-0002" content-type="Table"><label>Table 2</label><caption><p>Means and medians for the most purchased ATC main groups and subgroups of medications during the years 2005&#x02013;2017, as well as dental appointments and treatments during the years 2008&#x02013;2017.</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="left" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="center" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="center" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="center" span="1"/><thead valign="bottom"><tr valign="bottom" style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1"/><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">N</italic>
</th><th align="center" valign="bottom" rowspan="1" colspan="1">Mean (SD)</th><th align="center" valign="bottom" rowspan="1" colspan="1">Median</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Dental appointments</td><td align="center" valign="top" rowspan="1" colspan="1">1378</td><td align="center" valign="top" rowspan="1" colspan="1">36.0 (24.9)</td><td align="center" valign="top" rowspan="1" colspan="1">33</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Dental exam</td><td align="center" valign="top" rowspan="1" colspan="1">1373</td><td align="center" valign="top" rowspan="1" colspan="1">12.3 (8.1)</td><td align="center" valign="top" rowspan="1" colspan="1">12</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Fillings</td><td align="center" valign="top" rowspan="1" colspan="1">1263</td><td align="center" valign="top" rowspan="1" colspan="1">6.4 (6.8)</td><td align="center" valign="top" rowspan="1" colspan="1">5</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Periodontal treatment</td><td align="center" valign="top" rowspan="1" colspan="1">1123</td><td align="center" valign="top" rowspan="1" colspan="1">5.5 (5.9)</td><td align="center" valign="top" rowspan="1" colspan="1">4</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">X&#x02010;ray</td><td align="center" valign="top" rowspan="1" colspan="1">1068</td><td align="center" valign="top" rowspan="1" colspan="1">2.6 (2.9)</td><td align="center" valign="top" rowspan="1" colspan="1">2</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Extractions</td><td align="center" valign="top" rowspan="1" colspan="1">620</td><td align="center" valign="top" rowspan="1" colspan="1">0.9 (1.8)</td><td align="center" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Root canal treatment</td><td align="center" valign="top" rowspan="1" colspan="1">469</td><td align="center" valign="top" rowspan="1" colspan="1">0.8 (1.5)</td><td align="center" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Saliva test</td><td align="center" valign="top" rowspan="1" colspan="1">9</td><td align="center" valign="top" rowspan="1" colspan="1">0.01 (0.1)</td><td align="center" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">All types of medications</td><td align="center" valign="top" rowspan="1" colspan="1">1434</td><td align="center" valign="top" rowspan="1" colspan="1">146.1 (202.2)</td><td align="center" valign="top" rowspan="1" colspan="1">85</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Most purchased main ATC groups of medications</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Anti&#x02010;infectives for systemic use</td><td align="center" valign="top" rowspan="1" colspan="1">1287</td><td align="center" valign="top" rowspan="1" colspan="1">8.4 (22.4)</td><td align="center" valign="top" rowspan="1" colspan="1">4</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Nervous system</td><td align="center" valign="top" rowspan="1" colspan="1">1111</td><td align="center" valign="top" rowspan="1" colspan="1">36.9 (126.4)</td><td align="center" valign="top" rowspan="1" colspan="1">4</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Respiratory system</td><td align="center" valign="top" rowspan="1" colspan="1">1083</td><td align="center" valign="top" rowspan="1" colspan="1">12.6 (32.6)</td><td align="center" valign="top" rowspan="1" colspan="1">3</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Musculoskeletal system</td><td align="center" valign="top" rowspan="1" colspan="1">1080</td><td align="center" valign="top" rowspan="1" colspan="1">7.2 (17.8)</td><td align="center" valign="top" rowspan="1" colspan="1">2</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Alimentary tract and metabolism</td><td align="center" valign="top" rowspan="1" colspan="1">1024</td><td align="center" valign="top" rowspan="1" colspan="1">20.9 (50.5)</td><td align="center" valign="top" rowspan="1" colspan="1">3</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Cardiovascular system</td><td align="center" valign="top" rowspan="1" colspan="1">937</td><td align="center" valign="top" rowspan="1" colspan="1">34.2 (52.9)</td><td align="center" valign="top" rowspan="1" colspan="1">5</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Most purchased ATC subgroups of medications</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Antibacterials for systemic use</td><td align="center" valign="top" rowspan="1" colspan="1">1272</td><td align="center" valign="top" rowspan="1" colspan="1">5.6 (8.1)</td><td align="center" valign="top" rowspan="1" colspan="1">3</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Anti&#x02010;inflammatory and antirheumatic products</td><td align="center" valign="top" rowspan="1" colspan="1">1029</td><td align="center" valign="top" rowspan="1" colspan="1">4.8 (9.1)</td><td align="center" valign="top" rowspan="1" colspan="1">2</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Analgesics</td><td align="center" valign="top" rowspan="1" colspan="1">937</td><td align="center" valign="top" rowspan="1" colspan="1">8.9 (27.8)</td><td align="center" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Ophthalmological</td><td align="center" valign="top" rowspan="1" colspan="1">642</td><td align="center" valign="top" rowspan="1" colspan="1">4.7 (17.0)</td><td align="center" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Corticosteroids, dermatological preparations</td><td align="center" valign="top" rowspan="1" colspan="1">621</td><td align="center" valign="top" rowspan="1" colspan="1">2.1 (5.8)</td><td align="center" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Psycholeptics</td><td align="center" valign="top" rowspan="1" colspan="1">614</td><td align="center" valign="top" rowspan="1" colspan="1">12.6 (56.3)</td><td align="center" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Drugs for constipation</td><td align="center" valign="top" rowspan="1" colspan="1">602</td><td align="center" valign="top" rowspan="1" colspan="1">2.2 (7.1)</td><td align="center" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Nasal preparations</td><td align="center" valign="top" rowspan="1" colspan="1">601</td><td align="center" valign="top" rowspan="1" colspan="1">2.3 (6.8)</td><td align="center" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Cough and cold preparations</td><td align="center" valign="top" rowspan="1" colspan="1">598</td><td align="center" valign="top" rowspan="1" colspan="1">1.6 (5.5)</td><td align="center" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Drugs for acid&#x02010;related disorders</td><td align="center" valign="top" rowspan="1" colspan="1">578</td><td align="center" valign="top" rowspan="1" colspan="1">4.6 (14.4)</td><td align="center" valign="top" rowspan="1" colspan="1">0</td></tr></tbody></table><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap><p>Table&#x000a0;<xref rid="cre270121-tbl-0003" ref-type="table">3</xref> gives the number of medication purchases concerning the number of dental appointments. The results show that patients who had a high number of purchases of systemic medications had significantly more dental appointments than those with a low number of purchases. This was observed for all types of dental treatments. Only nine saliva tests were documented. These were made entirely on patients who had a high number of purchases of medications (<italic toggle="yes">p</italic>&#x02009;=&#x02009;0.002).</p><table-wrap position="float" id="cre270121-tbl-0003" content-type="Table"><label>Table 3</label><caption><p>Chi&#x02010;square tests for differences between high and low purchasers regarding different variables.</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="left" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="center" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="center" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="center" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="center" span="1"/><thead valign="bottom"><tr valign="bottom" style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Variable (higher dental appointments)</th><th align="center" valign="bottom" rowspan="1" colspan="1">High medication purchasers (%)</th><th align="center" valign="bottom" rowspan="1" colspan="1">Low medication purchasers (%)</th><th align="center" valign="bottom" rowspan="1" colspan="1">&#x003c7;<sup>2</sup>
</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic> value</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">All dental appointments</td><td align="center" valign="top" rowspan="1" colspan="1">56.3</td><td align="center" valign="top" rowspan="1" colspan="1">43.7</td><td align="center" valign="top" rowspan="1" colspan="1">31.00</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Dental examinations</td><td align="center" valign="top" rowspan="1" colspan="1">54.1</td><td align="center" valign="top" rowspan="1" colspan="1">45.9</td><td align="center" valign="top" rowspan="1" colspan="1">14.86</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Radiographs</td><td align="center" valign="top" rowspan="1" colspan="1">57.1</td><td align="center" valign="top" rowspan="1" colspan="1">42.9</td><td align="center" valign="top" rowspan="1" colspan="1">24.20</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Periodontal treatments</td><td align="center" valign="top" rowspan="1" colspan="1">51.9</td><td align="center" valign="top" rowspan="1" colspan="1">48.1</td><td align="center" valign="top" rowspan="1" colspan="1">4.01</td><td align="center" valign="top" rowspan="1" colspan="1">0.045</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Fillings</td><td align="center" valign="top" rowspan="1" colspan="1">53.9</td><td align="center" valign="top" rowspan="1" colspan="1">46.1</td><td align="center" valign="top" rowspan="1" colspan="1">13.69</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Extractions</td><td align="center" valign="top" rowspan="1" colspan="1">55.0</td><td align="center" valign="top" rowspan="1" colspan="1">45.0</td><td align="center" valign="top" rowspan="1" colspan="1">14.44</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Root canal treatment</td><td align="center" valign="top" rowspan="1" colspan="1">56.9</td><td align="center" valign="top" rowspan="1" colspan="1">43.1</td><td align="center" valign="top" rowspan="1" colspan="1">16.49</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;0.001</td></tr></tbody></table><table-wrap-foot><fn id="cre270121-tbl3-note-0001"><p>In the table are Chi&#x02010;square test of the distribution of data on four cells but only two cells are shown, for a complete distribution contact the first author. The degree of freedom of all variables are 1.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap><p>Table&#x000a0;<xref rid="cre270121-tbl-0004" ref-type="table">4</xref> gives a comprehensive overview of high and low purchasers of the systemic medications recorded and the number of dental appointments. When assessing the difference between high and low purchasers of medication regarding the number of dental appointments, a significant difference was noted in 12 out of 13 of the analyzed main ATC groups, and 32 out of 96 medication ATC subgroups, respectively. However, a similar trend was seen in all medication types. Not only known xerogenic medications were observed here but also drugs for the treatment of systemic inflammatory diseases and even purchasing flu medications were found in the analyses.</p><table-wrap position="float" id="cre270121-tbl-0004" content-type="Table"><label>Table 4</label><caption><p>
<italic toggle="yes">t</italic>&#x02010;test for differences between high and low number of dental appointments regarding medication purchases related to systemic inflammation.</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="left" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="center" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="center" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="center" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="center" span="1"/><thead valign="bottom"><tr valign="bottom" style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Variable (higher number of purchases)</th><th align="center" valign="bottom" rowspan="1" colspan="1">High number of dental appointments (%)</th><th align="center" valign="bottom" rowspan="1" colspan="1">Low number of dental appointments (%)</th><th align="center" valign="bottom" rowspan="1" colspan="1">&#x003c7;<sup>2</sup>
</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic> value</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">All types of medications above median</td><td align="center" valign="top" rowspan="1" colspan="1">57.8</td><td align="center" valign="top" rowspan="1" colspan="1">42.2</td><td align="center" valign="top" rowspan="1" colspan="1">31.00</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Alimentary tract and metabolism</td><td align="center" valign="top" rowspan="1" colspan="1">56.2</td><td align="center" valign="top" rowspan="1" colspan="1">43.8</td><td align="center" valign="top" rowspan="1" colspan="1">17.19</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Antidiarrheals, intestinal, anti&#x02010;inflammatory/anti&#x02010;infective agents</td><td align="center" valign="top" rowspan="1" colspan="1">60.4</td><td align="center" valign="top" rowspan="1" colspan="1">39.6</td><td align="center" valign="top" rowspan="1" colspan="1">8.19</td><td align="center" valign="top" rowspan="1" colspan="1">0.004</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Drugs used in diabetes</td><td align="center" valign="top" rowspan="1" colspan="1">55.2</td><td align="center" valign="top" rowspan="1" colspan="1">44.8</td><td align="center" valign="top" rowspan="1" colspan="1">1.31</td><td align="center" valign="top" rowspan="1" colspan="1">0.252</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cardiovascular system</td><td align="center" valign="top" rowspan="1" colspan="1">55.2</td><td align="center" valign="top" rowspan="1" colspan="1">44.8</td><td align="center" valign="top" rowspan="1" colspan="1">12.935</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;0.001</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Cardiac therapy</td><td align="center" valign="top" rowspan="1" colspan="1">51.5</td><td align="center" valign="top" rowspan="1" colspan="1">48.5</td><td align="center" valign="top" rowspan="1" colspan="1">0.09</td><td align="center" valign="top" rowspan="1" colspan="1">0.762</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Antihypertensives</td><td align="center" valign="top" rowspan="1" colspan="1">46.4</td><td align="center" valign="top" rowspan="1" colspan="1">53.6</td><td align="center" valign="top" rowspan="1" colspan="1">0.19</td><td align="center" valign="top" rowspan="1" colspan="1">0.663</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Diuretics</td><td align="center" valign="top" rowspan="1" colspan="1">53.6</td><td align="center" valign="top" rowspan="1" colspan="1">46.4</td><td align="center" valign="top" rowspan="1" colspan="1">1.49</td><td align="center" valign="top" rowspan="1" colspan="1">0.222</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Vasoprotectives</td><td align="center" valign="top" rowspan="1" colspan="1">61.5</td><td align="center" valign="top" rowspan="1" colspan="1">38.5</td><td align="center" valign="top" rowspan="1" colspan="1">9.76</td><td align="center" valign="top" rowspan="1" colspan="1">0.002</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Beta blocking agents</td><td align="center" valign="top" rowspan="1" colspan="1">55.8</td><td align="center" valign="top" rowspan="1" colspan="1">44.2</td><td align="center" valign="top" rowspan="1" colspan="1">7.03</td><td align="center" valign="top" rowspan="1" colspan="1">0.008</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Calcium channel blockers</td><td align="center" valign="top" rowspan="1" colspan="1">54.5</td><td align="center" valign="top" rowspan="1" colspan="1">45.5</td><td align="center" valign="top" rowspan="1" colspan="1">2.98</td><td align="center" valign="top" rowspan="1" colspan="1">0.084</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Agents acting on the renin&#x02010;angiotensin system</td><td align="center" valign="top" rowspan="1" colspan="1">55.4</td><td align="center" valign="top" rowspan="1" colspan="1">44.6</td><td align="center" valign="top" rowspan="1" colspan="1">8.76</td><td align="center" valign="top" rowspan="1" colspan="1">0.003</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Lipid modifying agents</td><td align="center" valign="top" rowspan="1" colspan="1">56.3</td><td align="center" valign="top" rowspan="1" colspan="1">43.8</td><td align="center" valign="top" rowspan="1" colspan="1">9.35</td><td align="center" valign="top" rowspan="1" colspan="1">0.002</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Dermatologicals</td><td align="center" valign="top" rowspan="1" colspan="1">60.4</td><td align="center" valign="top" rowspan="1" colspan="1">39.6</td><td align="center" valign="top" rowspan="1" colspan="1">53.21</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;0.001</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Antipsoriatics</td><td align="center" valign="top" rowspan="1" colspan="1">56.9</td><td align="center" valign="top" rowspan="1" colspan="1">43.1</td><td align="center" valign="top" rowspan="1" colspan="1">0.86</td><td align="center" valign="top" rowspan="1" colspan="1">0.355</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Corticosteroids, dermatological preparations</td><td align="center" valign="top" rowspan="1" colspan="1">58.9</td><td align="center" valign="top" rowspan="1" colspan="1">41.1</td><td align="center" valign="top" rowspan="1" colspan="1">30.24</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Systemic hormonal preparations, excl. sex hormones and insulins</td><td align="center" valign="top" rowspan="1" colspan="1">57.9</td><td align="center" valign="top" rowspan="1" colspan="1">42.1</td><td align="center" valign="top" rowspan="1" colspan="1">17.04</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;0.001</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Corticosteroids for systemic use</td><td align="center" valign="top" rowspan="1" colspan="1">56.9</td><td align="center" valign="top" rowspan="1" colspan="1">43.1</td><td align="center" valign="top" rowspan="1" colspan="1">9.15</td><td align="center" valign="top" rowspan="1" colspan="1">0.002</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Thyroid therapy</td><td align="center" valign="top" rowspan="1" colspan="1">60.8</td><td align="center" valign="top" rowspan="1" colspan="1">39.2</td><td align="center" valign="top" rowspan="1" colspan="1">7.99</td><td align="center" valign="top" rowspan="1" colspan="1">0.005</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Anti&#x02010;infectives for systemic use</td><td align="center" valign="top" rowspan="1" colspan="1">60.0</td><td align="center" valign="top" rowspan="1" colspan="1">40.0</td><td align="center" valign="top" rowspan="1" colspan="1">40.94</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;0.001</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Antibacterials for systemic use</td><td align="center" valign="top" rowspan="1" colspan="1">59.8</td><td align="center" valign="top" rowspan="1" colspan="1">40.2</td><td align="center" valign="top" rowspan="1" colspan="1">44.20</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Antineoplastic and immunomodulating agents</td><td align="center" valign="top" rowspan="1" colspan="1">56.0</td><td align="center" valign="top" rowspan="1" colspan="1">44.0</td><td align="center" valign="top" rowspan="1" colspan="1">1.90</td><td align="center" valign="top" rowspan="1" colspan="1">0.168</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Antineoplastic agents</td><td align="center" valign="top" rowspan="1" colspan="1">71.9</td><td align="center" valign="top" rowspan="1" colspan="1">28.1</td><td align="center" valign="top" rowspan="1" colspan="1">5.98</td><td align="center" valign="top" rowspan="1" colspan="1">0.015</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Musculo&#x02010;skeletal system</td><td align="center" valign="top" rowspan="1" colspan="1">54.8</td><td align="center" valign="top" rowspan="1" colspan="1">45.2</td><td align="center" valign="top" rowspan="1" colspan="1">9.68</td><td align="center" valign="top" rowspan="1" colspan="1">0.002</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Anti&#x02010;inflammatory and antirheumatic products</td><td align="center" valign="top" rowspan="1" colspan="1">55.7</td><td align="center" valign="top" rowspan="1" colspan="1">44.3</td><td align="center" valign="top" rowspan="1" colspan="1">11.02</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Nervous system</td><td align="center" valign="top" rowspan="1" colspan="1">54.3</td><td align="center" valign="top" rowspan="1" colspan="1">45.7</td><td align="center" valign="top" rowspan="1" colspan="1">8.06</td><td align="center" valign="top" rowspan="1" colspan="1">0.005</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Anesthetics</td><td align="center" valign="top" rowspan="1" colspan="1">67.2</td><td align="center" valign="top" rowspan="1" colspan="1">32.8</td><td align="center" valign="top" rowspan="1" colspan="1">7.45</td><td align="center" valign="top" rowspan="1" colspan="1">0.006</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Analgesics</td><td align="center" valign="top" rowspan="1" colspan="1">54.8</td><td align="center" valign="top" rowspan="1" colspan="1">45.2</td><td align="center" valign="top" rowspan="1" colspan="1">11.15</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;0.001</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Antiepileptics</td><td align="center" valign="top" rowspan="1" colspan="1">58.2</td><td align="center" valign="top" rowspan="1" colspan="1">41.8</td><td align="center" valign="top" rowspan="1" colspan="1">2.80</td><td align="center" valign="top" rowspan="1" colspan="1">0.094</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Anti&#x02010;parkinson drugs</td><td align="center" valign="top" rowspan="1" colspan="1">58.5</td><td align="center" valign="top" rowspan="1" colspan="1">41.5</td><td align="center" valign="top" rowspan="1" colspan="1">1.089</td><td align="center" valign="top" rowspan="1" colspan="1">0.297</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Psycholeptics</td><td align="center" valign="top" rowspan="1" colspan="1">53.6</td><td align="center" valign="top" rowspan="1" colspan="1">46.4</td><td align="center" valign="top" rowspan="1" colspan="1">3.96</td><td align="center" valign="top" rowspan="1" colspan="1">0.047</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Psychoanaleptics</td><td align="center" valign="top" rowspan="1" colspan="1">54.4</td><td align="center" valign="top" rowspan="1" colspan="1">45.6</td><td align="center" valign="top" rowspan="1" colspan="1">2.93</td><td align="center" valign="top" rowspan="1" colspan="1">0.087</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Other nervous system drugs</td><td align="center" valign="top" rowspan="1" colspan="1">55.4</td><td align="center" valign="top" rowspan="1" colspan="1">44.6</td><td align="center" valign="top" rowspan="1" colspan="1">0.95</td><td align="center" valign="top" rowspan="1" colspan="1">0.329</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Respiratory system</td><td align="center" valign="top" rowspan="1" colspan="1">57.5</td><td align="center" valign="top" rowspan="1" colspan="1">42.5</td><td align="center" valign="top" rowspan="1" colspan="1">24.05</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;0.001</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Drugs for obstructive airway diseases</td><td align="center" valign="top" rowspan="1" colspan="1">55.2</td><td align="center" valign="top" rowspan="1" colspan="1">44.8</td><td align="center" valign="top" rowspan="1" colspan="1">4.420</td><td align="center" valign="top" rowspan="1" colspan="1">0.036</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Antihistamines for systemic use</td><td align="center" valign="top" rowspan="1" colspan="1">54.8</td><td align="center" valign="top" rowspan="1" colspan="1">45.2</td><td align="center" valign="top" rowspan="1" colspan="1">5.03</td><td align="center" valign="top" rowspan="1" colspan="1">0.025</td></tr></tbody></table><table-wrap-foot><fn id="cre270121-tbl4-note-0001"><p>The table shows the chi&#x02010;square test of the distribution of data on four cells, but only two cells are shown. For a complete distribution, contact the first author. The degree of freedom of all variables is 1.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap><p>In addition to the ATC main groups and their subgroups given in Table&#x000a0;<xref rid="cre270121-tbl-0004" ref-type="table">4</xref>, significant differences were found regarding the higher number of medication purchases versus the number of dental appointments in other subgroups of medications. These ATC groups included the main group of genito&#x02010;urinary system and sex hormones (<italic toggle="yes">n</italic>&#x02009;=&#x02009;375, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.003), the subgroup of sex hormones and modulators of the genital system (<italic toggle="yes">n</italic>&#x02009;=&#x02009;264, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.010), medications for blood and blood&#x02010;forming organs (<italic toggle="yes">n</italic>&#x02009;=&#x02009;388, <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001), and drugs for anemia (<italic toggle="yes">n</italic>&#x02009;=&#x02009;176, <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001). Further, significant differences were also observed in the purchase of drugs for sensory organs (<italic toggle="yes">n</italic>&#x02009;=&#x02009;343, <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001), and ophthalmological and otological preparations (<italic toggle="yes">n</italic>&#x02009;=&#x02009;214, <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001). Antiparasitic products, insecticides, and repellents (<italic toggle="yes">n&#x02009;</italic>=&#x02009;336, <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001), and antiprotozoals (<italic toggle="yes">n</italic>&#x02009;=&#x02009;214, <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001), also showed significant differences with a higher number of purchases in the group with a higher number of dental appointments. For flu medications, a significant difference could be seen for nasal preparations (<italic toggle="yes">n&#x02009;</italic>=&#x02009;340, <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001) and cough and cold preparations (<italic toggle="yes">n</italic>&#x02009;=&#x02009;457, <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001). Among the gastrointestinal medications, antacids (<italic toggle="yes">n&#x02009;</italic>=&#x02009;314, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.019), mineral supplements (<italic toggle="yes">n</italic>&#x02009;=&#x02009;154, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.003), and stomatological preparations (<italic toggle="yes">n</italic>&#x02009;=&#x02009;157, <italic toggle="yes">p</italic>&#x02009;=&#x02009;&#x0003c;&#x02009;0.001), respectively, were associated with more dental appointments and treatments.</p><p>Table&#x000a0;<xref rid="cre270121-tbl-0005" ref-type="table">5</xref> reports the logistic regression analysis that was performed to examine the relationship between the frequency of the number of medications purchased and the number of dental appointments. The results showed that purchasing more medications were significantly associated with more dental appointments, even after adjusting for covariables.</p><table-wrap position="float" id="cre270121-tbl-0005" content-type="Table"><label>Table 5</label><caption><p>Logistic regression results for associations between medication purchases and dental appointments.</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="left" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="center" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="center" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="center" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="center" span="1"/><thead valign="bottom"><tr valign="bottom" style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Medication purchase versus dental appointment</th><th align="center" valign="bottom" rowspan="1" colspan="1">Significance</th><th align="center" valign="bottom" rowspan="1" colspan="1">OR (95%)</th><th align="center" valign="bottom" rowspan="1" colspan="1">Cl lower</th><th align="center" valign="bottom" rowspan="1" colspan="1">Cl higher</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Dental appointments above the median</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;0.001</td><td align="center" valign="top" rowspan="1" colspan="1">1.759</td><td align="center" valign="top" rowspan="1" colspan="1">1.425</td><td align="center" valign="top" rowspan="1" colspan="1">2.171</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Man (sex)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;00.001</td><td align="center" valign="top" rowspan="1" colspan="1">0.672</td><td align="center" valign="top" rowspan="1" colspan="1">0.544</td><td align="center" valign="top" rowspan="1" colspan="1">0.829</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Tobacco consumption in 1985</td><td align="center" valign="top" rowspan="1" colspan="1">0.023</td><td align="center" valign="top" rowspan="1" colspan="1">1.291</td><td align="center" valign="top" rowspan="1" colspan="1">1.036</td><td align="center" valign="top" rowspan="1" colspan="1">1.610</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Diagnosis before 1985</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;00.001</td><td align="center" valign="top" rowspan="1" colspan="1">1.658</td><td align="center" valign="top" rowspan="1" colspan="1">1.328</td><td align="center" valign="top" rowspan="1" colspan="1">2.070</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Low socioeconomic status in 1985</td><td align="center" valign="top" rowspan="1" colspan="1">0.017</td><td align="center" valign="top" rowspan="1" colspan="1">0.830</td><td align="center" valign="top" rowspan="1" colspan="1">0.637</td><td align="center" valign="top" rowspan="1" colspan="1">1.083</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Dental examinations above the median</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;00.001</td><td align="center" valign="top" rowspan="1" colspan="1">1.468</td><td align="center" valign="top" rowspan="1" colspan="1">1.191</td><td align="center" valign="top" rowspan="1" colspan="1">1.809</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Man (sex)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;00.001</td><td align="center" valign="top" rowspan="1" colspan="1">0.674</td><td align="center" valign="top" rowspan="1" colspan="1">0.547</td><td align="center" valign="top" rowspan="1" colspan="1">0.831</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Tobacco consumption in 1985</td><td align="center" valign="top" rowspan="1" colspan="1">0.007</td><td align="center" valign="top" rowspan="1" colspan="1">1.352</td><td align="center" valign="top" rowspan="1" colspan="1">1.087</td><td align="center" valign="top" rowspan="1" colspan="1">1.683</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Diagnosis before 1985</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;00.001</td><td align="center" valign="top" rowspan="1" colspan="1">1.635</td><td align="center" valign="top" rowspan="1" colspan="1">1.312</td><td align="center" valign="top" rowspan="1" colspan="1">2.039</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Low socioeconomic status in 1985</td><td align="center" valign="top" rowspan="1" colspan="1">0.0143</td><td align="center" valign="top" rowspan="1" colspan="1">0.820</td><td align="center" valign="top" rowspan="1" colspan="1">0.630</td><td align="center" valign="top" rowspan="1" colspan="1">1.069</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Dental radiographs above the median</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;00.001</td><td align="center" valign="top" rowspan="1" colspan="1">1.588</td><td align="center" valign="top" rowspan="1" colspan="1">1.282</td><td align="center" valign="top" rowspan="1" colspan="1">1.966</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Man (sex)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;00.001</td><td align="center" valign="top" rowspan="1" colspan="1">0.671</td><td align="center" valign="top" rowspan="1" colspan="1">0.544</td><td align="center" valign="top" rowspan="1" colspan="1">0.827</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Tobacco consumption in 1985</td><td align="center" valign="top" rowspan="1" colspan="1">0.010</td><td align="center" valign="top" rowspan="1" colspan="1">1.334</td><td align="center" valign="top" rowspan="1" colspan="1">1.071</td><td align="center" valign="top" rowspan="1" colspan="1">1.661</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Diagnosis before 1985</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;00.001</td><td align="center" valign="top" rowspan="1" colspan="1">1.564</td><td align="center" valign="top" rowspan="1" colspan="1">1.255</td><td align="center" valign="top" rowspan="1" colspan="1">1.951</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Low socioeconomic status in 1985</td><td align="center" valign="top" rowspan="1" colspan="1">0.111</td><td align="center" valign="top" rowspan="1" colspan="1">0.807</td><td align="center" valign="top" rowspan="1" colspan="1">0.620</td><td align="center" valign="top" rowspan="1" colspan="1">1.050</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Anti&#x02010;infective treatments above the median</td><td align="center" valign="top" rowspan="1" colspan="1">0.043</td><td align="center" valign="top" rowspan="1" colspan="1">1.243</td><td align="center" valign="top" rowspan="1" colspan="1">1.007</td><td align="center" valign="top" rowspan="1" colspan="1">1.533</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Man (sex)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;00.001</td><td align="center" valign="top" rowspan="1" colspan="1">0.668</td><td align="center" valign="top" rowspan="1" colspan="1">0.543</td><td align="center" valign="top" rowspan="1" colspan="1">0.824</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Tobacco consumption in 1985</td><td align="center" valign="top" rowspan="1" colspan="1">0.007</td><td align="center" valign="top" rowspan="1" colspan="1">1.352</td><td align="center" valign="top" rowspan="1" colspan="1">1.087</td><td align="center" valign="top" rowspan="1" colspan="1">1.682</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Diagnosis before 1985</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;00.001</td><td align="center" valign="top" rowspan="1" colspan="1">1.644</td><td align="center" valign="top" rowspan="1" colspan="1">1.318</td><td align="center" valign="top" rowspan="1" colspan="1">2.052</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Low socioeconomic status in 1985</td><td align="center" valign="top" rowspan="1" colspan="1">0.104</td><td align="center" valign="top" rowspan="1" colspan="1">0.804</td><td align="center" valign="top" rowspan="1" colspan="1">0.612</td><td align="center" valign="top" rowspan="1" colspan="1">1.046</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Placing fillings above median</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;00.001</td><td align="center" valign="top" rowspan="1" colspan="1">1.427</td><td align="center" valign="top" rowspan="1" colspan="1">1.160</td><td align="center" valign="top" rowspan="1" colspan="1">1.755</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Man (sex)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;00.001</td><td align="center" valign="top" rowspan="1" colspan="1">0.671</td><td align="center" valign="top" rowspan="1" colspan="1">0.545</td><td align="center" valign="top" rowspan="1" colspan="1">0.827</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Tobacco consumption in 1985</td><td align="center" valign="top" rowspan="1" colspan="1">0.005</td><td align="center" valign="top" rowspan="1" colspan="1">1.364</td><td align="center" valign="top" rowspan="1" colspan="1">1.096</td><td align="center" valign="top" rowspan="1" colspan="1">1.696</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Diagnosis before 1985</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;00.001</td><td align="center" valign="top" rowspan="1" colspan="1">1.600</td><td align="center" valign="top" rowspan="1" colspan="1">1.284</td><td align="center" valign="top" rowspan="1" colspan="1">1.994</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Low socioeconomic status in 1985</td><td align="center" valign="top" rowspan="1" colspan="1">0.085</td><td align="center" valign="top" rowspan="1" colspan="1">0.793</td><td align="center" valign="top" rowspan="1" colspan="1">0.610</td><td align="center" valign="top" rowspan="1" colspan="1">1.032</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Extractions above median</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;00.001</td><td align="center" valign="top" rowspan="1" colspan="1">1.442</td><td align="center" valign="top" rowspan="1" colspan="1">1.167</td><td align="center" valign="top" rowspan="1" colspan="1">1.782</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Man (sex)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;00.001</td><td align="center" valign="top" rowspan="1" colspan="1">0.655</td><td align="center" valign="top" rowspan="1" colspan="1">0.532</td><td align="center" valign="top" rowspan="1" colspan="1">0.808</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Tobacco consumption in 1985</td><td align="center" valign="top" rowspan="1" colspan="1">0.016</td><td align="center" valign="top" rowspan="1" colspan="1">1.310</td><td align="center" valign="top" rowspan="1" colspan="1">1.052</td><td align="center" valign="top" rowspan="1" colspan="1">1.633</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Diagnosis before 1985</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;00.001</td><td align="center" valign="top" rowspan="1" colspan="1">1.589</td><td align="center" valign="top" rowspan="1" colspan="1">1.275</td><td align="center" valign="top" rowspan="1" colspan="1">1.981</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Low socioeconomic status in 1985</td><td align="center" valign="top" rowspan="1" colspan="1">0.067</td><td align="center" valign="top" rowspan="1" colspan="1">0.797</td><td align="center" valign="top" rowspan="1" colspan="1">0.613</td><td align="center" valign="top" rowspan="1" colspan="1">1.038</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Root canal treatments above the median</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;00.001</td><td align="center" valign="top" rowspan="1" colspan="1">1.500</td><td align="center" valign="top" rowspan="1" colspan="1">1.199</td><td align="center" valign="top" rowspan="1" colspan="1">1.877</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Man (sex)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;00.001</td><td align="center" valign="top" rowspan="1" colspan="1">0.667</td><td align="center" valign="top" rowspan="1" colspan="1">0.541</td><td align="center" valign="top" rowspan="1" colspan="1">.823</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Tobacco consumption in 1985</td><td align="center" valign="top" rowspan="1" colspan="1">0.005</td><td align="center" valign="top" rowspan="1" colspan="1">1.364</td><td align="center" valign="top" rowspan="1" colspan="1">1.096</td><td align="center" valign="top" rowspan="1" colspan="1">1.697</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Diagnosis before 1985</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;00.001</td><td align="center" valign="top" rowspan="1" colspan="1">1.571</td><td align="center" valign="top" rowspan="1" colspan="1">1.260</td><td align="center" valign="top" rowspan="1" colspan="1">1.958</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Low socioeconomic status in 1985</td><td align="center" valign="top" rowspan="1" colspan="1">0.110</td><td align="center" valign="top" rowspan="1" colspan="1">0.807</td><td align="center" valign="top" rowspan="1" colspan="1">0.620</td><td align="center" valign="top" rowspan="1" colspan="1">1.050</td></tr></tbody></table><table-wrap-foot><fn id="cre270121-tbl5-note-0001"><p>Significance was set at <italic toggle="yes">p</italic>&#x02010;value&#x02009;&#x0003c;&#x02009;0&#x02009;0.05.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap><p>Table&#x000a0;<xref rid="cre270121-tbl-0006" ref-type="table">6</xref> gives the results of the logistic regression analyses on the purchase of medications used for inflammatory diseases versus dental appointments. The associations were significant even when considering all the covariates. Hence, a significant positive association was found between the number of medication purchases and the number of dental appointments. A more frequent number of dental appointments was found in 12 out of 13 of the ATC groups of medications as well as in 32 ATC subgroups of medications, respectively.</p><table-wrap position="float" id="cre270121-tbl-0006" content-type="Table"><label>Table 6,</label><caption><p>Logistic regressions for associations between the number of dental appointments and purchases of medications used for treating systemic inflammatory diseases.</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="left" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="center" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="center" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="center" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="center" span="1"/><thead valign="bottom"><tr valign="bottom" style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Dental visits versus medication main ATC groups and subgroups</th><th align="center" valign="bottom" rowspan="1" colspan="1">Significance</th><th align="center" valign="bottom" rowspan="1" colspan="1">OR (95%)</th><th align="center" valign="bottom" rowspan="1" colspan="1">Cl lower</th><th align="center" valign="bottom" rowspan="1" colspan="1">Cl higher</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Alimentary tract and metabolism</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;00.001</td><td align="center" valign="top" rowspan="1" colspan="1">1.759</td><td align="center" valign="top" rowspan="1" colspan="1">1.425</td><td align="center" valign="top" rowspan="1" colspan="1">2.170</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Drugs used in diabetes</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;00.001</td><td align="center" valign="top" rowspan="1" colspan="1">1.566</td><td align="center" valign="top" rowspan="1" colspan="1">1.268</td><td align="center" valign="top" rowspan="1" colspan="1">1.933</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Antidiarrheals, intestinal, anti&#x02010;inflammatory/anti&#x02010;infective agents</td><td align="center" valign="top" rowspan="1" colspan="1">0.132</td><td align="center" valign="top" rowspan="1" colspan="1">1.322</td><td align="center" valign="top" rowspan="1" colspan="1">0.919</td><td align="center" valign="top" rowspan="1" colspan="1">1.902</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Cardiovascular system</td><td align="center" valign="top" rowspan="1" colspan="1">0.006</td><td align="center" valign="top" rowspan="1" colspan="1">1.577</td><td align="center" valign="top" rowspan="1" colspan="1">1.141</td><td align="center" valign="top" rowspan="1" colspan="1">1.773</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Vasoprotectives</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;00.001</td><td align="center" valign="top" rowspan="1" colspan="1">1.451</td><td align="center" valign="top" rowspan="1" colspan="1">1.180</td><td align="center" valign="top" rowspan="1" colspan="1">1.785</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Beta blocking agents</td><td align="center" valign="top" rowspan="1" colspan="1">0.001</td><td align="center" valign="top" rowspan="1" colspan="1">1.697</td><td align="center" valign="top" rowspan="1" colspan="1">1.227</td><td align="center" valign="top" rowspan="1" colspan="1">2.346</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Agents acting on the renin&#x02010;angiotensin system</td><td align="center" valign="top" rowspan="1" colspan="1">0.012</td><td align="center" valign="top" rowspan="1" colspan="1">1.339</td><td align="center" valign="top" rowspan="1" colspan="1">1.065</td><td align="center" valign="top" rowspan="1" colspan="1">1.683</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Lipid modifying agents</td><td align="center" valign="top" rowspan="1" colspan="1">0.004</td><td align="center" valign="top" rowspan="1" colspan="1">1.366</td><td align="center" valign="top" rowspan="1" colspan="1">1.103</td><td align="center" valign="top" rowspan="1" colspan="1">1.690</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Dermatological</td><td align="center" valign="top" rowspan="1" colspan="1">.003</td><td align="center" valign="top" rowspan="1" colspan="1">1.392</td><td align="center" valign="top" rowspan="1" colspan="1">1.115</td><td align="center" valign="top" rowspan="1" colspan="1">1.739</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Antibiotics and chemotherapeutics for dermatological use</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;00.001</td><td align="center" valign="top" rowspan="1" colspan="1">2.194</td><td align="center" valign="top" rowspan="1" colspan="1">1.777</td><td align="center" valign="top" rowspan="1" colspan="1">2.709</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Corticosteroids, dermatological preparations</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;00.001</td><td align="center" valign="top" rowspan="1" colspan="1">2.013</td><td align="center" valign="top" rowspan="1" colspan="1">1.467</td><td align="center" valign="top" rowspan="1" colspan="1">2.761</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Systemic hormonal preparations, excluding sex hormones and insulins</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;00.001</td><td align="center" valign="top" rowspan="1" colspan="1">1.744</td><td align="center" valign="top" rowspan="1" colspan="1">1.411</td><td align="center" valign="top" rowspan="1" colspan="1">2.155</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Corticosteroids for systemic use</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;00.001</td><td align="center" valign="top" rowspan="1" colspan="1">1.581</td><td align="center" valign="top" rowspan="1" colspan="1">1.265</td><td align="center" valign="top" rowspan="1" colspan="1">1.975</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Anti&#x02010;infectives for systemic use</td><td align="center" valign="top" rowspan="1" colspan="1">0.005</td><td align="center" valign="top" rowspan="1" colspan="1">1.642</td><td align="center" valign="top" rowspan="1" colspan="1">1.166</td><td align="center" valign="top" rowspan="1" colspan="1">2.313</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Antibacterials for systemic use</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;00.001</td><td align="center" valign="top" rowspan="1" colspan="1">1.986</td><td align="center" valign="top" rowspan="1" colspan="1">1.602</td><td align="center" valign="top" rowspan="1" colspan="1">2.462</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Antineoplastic and immunomodulating agents</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;00.001</td><td align="center" valign="top" rowspan="1" colspan="1">3.160</td><td align="center" valign="top" rowspan="1" colspan="1">2.292</td><td align="center" valign="top" rowspan="1" colspan="1">4.357</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Antineoplastic agents</td><td align="center" valign="top" rowspan="1" colspan="1">0.202</td><td align="center" valign="top" rowspan="1" colspan="1">1.260</td><td align="center" valign="top" rowspan="1" colspan="1">.884</td><td align="center" valign="top" rowspan="1" colspan="1">1.795</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Musculoskeletal system</td><td align="center" valign="top" rowspan="1" colspan="1">0.021</td><td align="center" valign="top" rowspan="1" colspan="1">2.512</td><td align="center" valign="top" rowspan="1" colspan="1">1.149</td><td align="center" valign="top" rowspan="1" colspan="1">5.494</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Anti&#x02010;inflammatory and antirheumatic products</td><td align="center" valign="top" rowspan="1" colspan="1">0.002</td><td align="center" valign="top" rowspan="1" colspan="1">1.403</td><td align="center" valign="top" rowspan="1" colspan="1">1.138</td><td align="center" valign="top" rowspan="1" colspan="1">1.729</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Nervous system</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;00.001</td><td align="center" valign="top" rowspan="1" colspan="1">1.871</td><td align="center" valign="top" rowspan="1" colspan="1">1.490</td><td align="center" valign="top" rowspan="1" colspan="1">2.351</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Anesthetics</td><td align="center" valign="top" rowspan="1" colspan="1">0.009</td><td align="center" valign="top" rowspan="1" colspan="1">1.323</td><td align="center" valign="top" rowspan="1" colspan="1">1.072</td><td align="center" valign="top" rowspan="1" colspan="1">1.633</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Analgesics</td><td align="center" valign="top" rowspan="1" colspan="1">0.022</td><td align="center" valign="top" rowspan="1" colspan="1">1.882</td><td align="center" valign="top" rowspan="1" colspan="1">1.096</td><td align="center" valign="top" rowspan="1" colspan="1">3.230</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Respiratory system</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;00.001</td><td align="center" valign="top" rowspan="1" colspan="1">1.579</td><td align="center" valign="top" rowspan="1" colspan="1">1.272</td><td align="center" valign="top" rowspan="1" colspan="1">1.959</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Drugs for obstructive airway diseases</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;00.001</td><td align="center" valign="top" rowspan="1" colspan="1">1.685</td><td align="center" valign="top" rowspan="1" colspan="1">1.362</td><td align="center" valign="top" rowspan="1" colspan="1">2.086</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Antihistamines for systemic use</td><td align="center" valign="top" rowspan="1" colspan="1">0.048</td><td align="center" valign="top" rowspan="1" colspan="1">1.276</td><td align="center" valign="top" rowspan="1" colspan="1">1.003</td><td align="center" valign="top" rowspan="1" colspan="1">1.624</td></tr></tbody></table><table-wrap-foot><fn id="cre270121-tbl6-note-0001"><p>Covariates included in the analysis were the ATC main and subgroups for medications, sex, tobacco consumption in 1985, a periodontal diagnosis in 1985, hospital diagnosis before 1985 and low socioeconomic status in 1985. Significance was set at <italic toggle="yes">p</italic>&#x02010;value&#x02009;&#x0003c;&#x02009;0&#x02009;0.05.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap></sec><sec sec-type="discussion" id="cre270121-sec-0090"><label>4</label><title>Discussion</title><p>The main hypothesis of the present study was that participants purchasing a high number of medications have more dental appointments and treatments when compared with those purchasing fewer medications. Our findings confirmed the hypothesis. Medication purchases above the median posed a higher statistical risk for more dental appointments and, subsequently, presumably indicated poorer oral health. A significant association was indeed found between all the ATC main groups of medications and dental appointments, except for antineoplastic and immunomodulating agents. A significant association was also found for over a third of the 2nd&#x02010;level ATC subgroups of medications. These findings are in line with earlier research on polypharmacy and comorbidities that have been associated with low salivary flow and subsequent dry mouth in the elderly (Smidt et al.&#x000a0;<xref rid="cre270121-bib-0025" ref-type="bibr">2010</xref>).</p><p>Purchasing more vasoprotective drugs, beta&#x02010;blocking agents, medicines acting on the renin&#x02010;angiotensin system, and lipid&#x02010;modifying agents, was associated with a significantly higher number of dental appointments and treatments. Indeed, many medications have been linked to hyposalivation, and, in particular, cardiovascular drugs are known to be xerogenic, thus affecting oral health (Schenkein et al.&#x000a0;<xref rid="cre270121-bib-0023" ref-type="bibr">2020</xref>). Whether the observed polypharmacy and a higher medication purchase of almost all medication groups indicate a higher risk for worse oral health nevertheless calls for more studies. Heterogeneity among studies on dry mouth and the role of polypharmacy in it still poses a challenge for evidence (Wiriyakijja et al.&#x000a0;<xref rid="cre270121-bib-0037" ref-type="bibr">2023</xref>).</p><p>The long&#x02010;term follow&#x02010;up of our patients offered an insight into how long&#x02010;term oral health, systemic health, medication use, and socioeconomic status affect a patient. The registers at hand were extensive. The pharmacological register used here provided a unique possibility for analyzing the relationships between medication purchases and the number of dental appointments, which is a strength in our study. However, the longevity of the study also poses challenges, since medication purchases and everyday habits may differ from year to year. These data are missing. Tracking changes in medications is problematic, as the initial treatment does not necessarily suit the patient thus requiring a change both in the medication type and dosage. This may even lead to changes in the ATC medication groups, something that could not be tracked in our study. Furthermore, in the registers at hand, one could not follow smoking, snus, or nicotine product use throughout the decades, which is a weakness. Oral health habits and alcohol use were not included in the registers, which also was unfortunate.</p><p>Periodontitis has been associated with systemic chronic inflammatory comorbidities (Hajishengallis and Chavakis&#x000a0;<xref rid="cre270121-bib-0006" ref-type="bibr">2021</xref>). Notable conditions are cardiovascular diseases, diabetes, inflammatory bowel diseases, gastrointestinal and colorectal cancer, neurodegenerative diseases, rheumatic diseases, adverse pregnancy outcomes, as well as respiratory tract infections (Herrera et al.&#x000a0;<xref rid="cre270121-bib-0009" ref-type="bibr">2024</xref>; Bui et al.&#x000a0;<xref rid="cre270121-bib-0003" ref-type="bibr">2019</xref>). In our study, a significant association was observed between the number of dental appointments and the number of purchases of the drugs used for systemic inflammatory disease. Yet, when assessing for confounders, periodontitis at baseline was not significantly associated with the purchase of medicines later in life. On the other hand, hospital diagnosis before baseline in 1985 was a significant &#x0201c;protective factor&#x0201d; for most ATC groups and subgroups of medications. Associations of systemic corticosteroids, anti&#x02010;inflammatory medications, and anti&#x02010;infectives for systemic and dermatological use with more dental appointments were also found. Antibiotics contain a broad range of drugs such as tetracyclines, beta&#x02010;lactam antibacterials, sulfonamides, trimethoprim, and macrolides. Penicillin, metronidazole, cefalexin, and clindamycin, are antibiotics also used in dentistry since oral pathogens have been linked to a higher risk of infections (Han and Wang&#x000a0;<xref rid="cre270121-bib-0007" ref-type="bibr">2013</xref>). Anti&#x02010;virals, such as acyclovir, are used for treating viral infections such as herpes lesions, which also can lead to more dental appointments. Earlier research suggests a connection between periodontitis, viruses, and comorbidities (Teles et al.&#x000a0;<xref rid="cre270121-bib-0030" ref-type="bibr">2022</xref>). In our study, even cold and flu medication purchases were associated with more dental appointments. These medications can also cause dry mouth. On the other hand, pericoronitis, for example, has earlier been linked to more flu episodes among men doing their military service in Finland (Meurman et al.&#x000a0;<xref rid="cre270121-bib-0020" ref-type="bibr">1995</xref>), so there seems to be a bidirectional relationship even here.</p><p>Antineoplastic agents are a very diverse pharmacological group. A significant association between this ATC main group and the number of dental appointments could not be established. However, when analyzing the largest ATC subgroup of neoplastic agents, a significant association was found. Neurological and psychiatric diseases such as Alzheimer's, Parkinson's, and depression, have also been associated with periodontitis (Liccardo et al.&#x000a0;<xref rid="cre270121-bib-0016" ref-type="bibr">2019</xref>; Chen et al.&#x000a0;<xref rid="cre270121-bib-0004" ref-type="bibr">2017</xref>). In the present study, more dental appointments were significantly associated with purchasing more than the median of the nervous system drugs in general. However, a significant association between purchasing antiepileptics, antiparkinson drugs, or psycholeptics and the number of dental appointments could not be found. An association between analgesics and anesthetics could, however, be found. As these drugs are routinely used also in dentistry, the result was not unexpected.</p><p>Drugs for obstructive airway diseases are known to be associated with periodontitis, but asthma medications are also associated with a higher risk of oral candidiasis and caries (Moreira et al.&#x000a0;<xref rid="cre270121-bib-0021" ref-type="bibr">2023</xref>; Thomas et al.&#x000a0;<xref rid="cre270121-bib-0031" ref-type="bibr">2010</xref>). In addition, purchasing ophthalmological drugs was associated with more dental appointments. This might explain that both the daily intake of many drugs and systemic diseases themselves link to both oral and ocular dryness (Smidt et al.&#x000a0;<xref rid="cre270121-bib-0026" ref-type="bibr">2011</xref>). In addition, another possible link can be speculated because impaired vision may affect oral healthcare and consequently reflects in the higher need for dental treatments (Blanco L&#x000f3;pez et al.&#x000a0;<xref rid="cre270121-bib-0002" ref-type="bibr">2023</xref>).</p><p>Furthermore, diabetes is associated with periodontitis and the risk of caries (Larvin et al.&#x000a0;<xref rid="cre270121-bib-0015" ref-type="bibr">2023</xref>). However, in our study, the lack of a significant association between the number of dental appointments and purchases of diabetes medications was surprising. Socioeconomic status, in turn, has been linked to disease development, medication purchases, worse oral health, and poorer oral health&#x02010;related quality of life (Knorst et al.&#x000a0;<xref rid="cre270121-bib-0014" ref-type="bibr">2021</xref>; Iqbal et al.&#x000a0;<xref rid="cre270121-bib-0010" ref-type="bibr">2023</xref>). In our study, low socioeconomic status at baseline negatively correlated with the number of medication purchases and dental appointments above the median. This might be due to the high costs of medications and appointments among the disadvantaged and participants with lesser means.</p><p>Some possible causal mechanisms for the observed associations still need to be discussed. These include poor oral hygiene, trauma, tobacco use and diet. In the adjusted odds ratios, which included the covariates like tobacco use and periodontal status at baseline, further mechanisms for example, dietary habits had not been recorded. The eventual causal pathways between medication purchases, diet, and oral hygiene thus require further investigation.</p><p>To conclude, in the group of adult Swedes who were studied, the present results confirmed our hypothesis by showing that a higher number of purchased medications was associated with the number of dental appointments and treatments. Since most of the medication ATC main groups and subgroups, and especially the drugs used for systemic inflammatory diseases, were associated with more dental appointments and treatments, the result indicates that not only anticholinergic drugs but simply polypharmacy and higher medication use in general potentially affects oral health negatively. This leads to an increased need for dental appointments. This is in line with the paradigm that oral health is connected to systemic health.</p></sec><sec id="cre270121-sec-0100"><title>Author Contributions</title><p>Birgitta S&#x000f6;der and Jukka Meurman contributed to the conception, design, data acquisition, and interpretation, and critically revised the manuscript. H&#x000e5;kan K&#x000e4;llm&#x000e9;n and Esa Korpi contributed to data analysis and interpretation and critically revised the manuscript. Freja Frankenhaeuser conducted the main part of the analyses, contributed to the design and data interpretation and drafted the manuscript. All authors gave final approval and agreed to be accountable for all aspects of the work.</p></sec><sec id="cre270121-sec-0120"><title>Ethics Statement</title><p>The Ethics Committee of the Karolinska University Hospital at Huddinge had approved the study (Dnr 2007/1669&#x02013;31; 2012/590&#x02013;32; 2017/2204&#x02013;32).</p></sec><sec id="cre270121-sec-0130"><title>Consent</title><p>This is a register study. Written informed consent was not required.</p></sec><sec sec-type="COI-statement" id="cre270121-sec-0140"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="cre270121-suppl-0001" position="float" content-type="local-data"><caption><p>Attachment 1. Complete list of means and medians for all ATC main groups and subgroups of medication purchases.</p></caption><media xlink:href="CRE2-11-e70121-s001.docx"/></supplementary-material></sec></body><back><ack id="cre270121-sec-0110"><title>Acknowledgments</title><p>This study was supported by the Swedish Ministry of Health and Social Affairs (grants F84/189), Karolinska Institutet, and King Gustav V&#x000b4;s and Queen Victoria Freemason&#x000b4;s Foundation, Sweden. Other grants have been received from The Finnish Society of Sciences and Letters, The Finnish Medical Society, and Odontologiska Samfundet, Finland.</p></ack><sec sec-type="data-availability" id="cre270121-sec-0160"><title>Data Availability Statement</title><p>The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.</p></sec><ref-list content-type="cited-references" id="cre270121-bibl-0001"><title>References</title><ref id="cre270121-bib-0001"><mixed-citation publication-type="journal" id="cre270121-cit-0001">
<string-name>
<surname>Barbe</surname>, <given-names>A. G.</given-names>
</string-name>
<year>2018</year>. &#x0201c;<article-title>Medication&#x02010;Induced Xerostomia and Hyposalivation in the Elderly: Culprits, Complications, and Management</article-title>.&#x0201d; <source>Drugs &#x00026; Aging</source>
<volume>35</volume>, no. <issue>10</issue>: <fpage>877</fpage>&#x02013;<lpage>885</lpage>.<pub-id pub-id-type="pmid">30187289</pub-id>
</mixed-citation></ref><ref id="cre270121-bib-0002"><mixed-citation publication-type="journal" id="cre270121-cit-0002">
<string-name>
<surname>Blanco L&#x000f3;pez</surname>, <given-names>M. A.</given-names>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Diniz Freitas</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Limeres Posse</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Hern&#x000e1;ndez&#x02010;Vallejo</surname>
</string-name>, and <string-name>
<given-names>R. M.</given-names>
<surname>L&#x000f3;pez&#x02010;Pintor</surname>
</string-name>. <year>2023</year>. &#x0201c;<article-title>Oral Health Status and Dental Care for Individuals With Visual Impairment. A Narrative Review</article-title>.&#x0201d; <source>Special Care in Dentistry</source>
<volume>43</volume>, no. <issue>2</issue>: <fpage>221</fpage>&#x02013;<lpage>231</lpage>.<pub-id pub-id-type="pmid">35941095</pub-id>
</mixed-citation></ref><ref id="cre270121-bib-0003"><mixed-citation publication-type="journal" id="cre270121-cit-0003">
<string-name>
<surname>Bui</surname>, <given-names>F. Q.</given-names>
</string-name>, <string-name>
<given-names>C. L. C.</given-names>
<surname>Almeida&#x02010;da&#x02010;Silva</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Huynh</surname>
</string-name>, et al. <year>2019</year>. &#x0201c;<article-title>Association Between Periodontal Pathogens and Systemic Disease</article-title>.&#x0201d; <source>Biomedical Journal</source>
<volume>42</volume>, no. <issue>1</issue>: <fpage>27</fpage>&#x02013;<lpage>35</lpage>.<pub-id pub-id-type="pmid">30987702</pub-id>
</mixed-citation></ref><ref id="cre270121-bib-0004"><mixed-citation publication-type="journal" id="cre270121-cit-0004">
<string-name>
<surname>Chen</surname>, <given-names>C. K.</given-names>
</string-name>, <string-name>
<given-names>Y. T.</given-names>
<surname>Wu</surname>
</string-name>, and <string-name>
<given-names>Y. C.</given-names>
<surname>Chang</surname>
</string-name>. <year>2017</year>. &#x0201c;<article-title>Association Between Chronic Periodontitis and the Risk of Alzheimer's Disease: A Retrospective, Population&#x02010;Based, Matched&#x02010;Cohort Study</article-title>.&#x0201d; <source>Alzheimer's Research &#x00026; Therapy</source>
<volume>9</volume>, no. <issue>1</issue>: <fpage>56</fpage>.</mixed-citation></ref><ref id="cre270121-bib-0005"><mixed-citation publication-type="journal" id="cre270121-cit-0005">
<string-name>
<surname>Daunt</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Curtin</surname>
</string-name>, and <string-name>
<given-names>D.</given-names>
<surname>O'Mahony</surname>
</string-name>. <year>2023</year>. &#x0201c;<article-title>Polypharmacy Stewardship: A Novel Approach to Tackle a Major Public Health Crisis</article-title>.&#x0201d; <source>Lancet Healthy Longevity</source>
<volume>4</volume>, no. <issue>5</issue>: <fpage>e228</fpage>&#x02013;<lpage>e235</lpage>.<pub-id pub-id-type="pmid">37030320</pub-id>
</mixed-citation></ref><ref id="cre270121-bib-0006"><mixed-citation publication-type="journal" id="cre270121-cit-0006">
<string-name>
<surname>Hajishengallis</surname>, <given-names>G.</given-names>
</string-name>, and <string-name>
<given-names>T.</given-names>
<surname>Chavakis</surname>
</string-name>. <year>2021</year>. &#x0201c;<article-title>Local and Systemic Mechanisms Linking Periodontal Disease and Inflammatory Comorbidities</article-title>.&#x0201d; <source>Nature Reviews Immunology</source>
<volume>21</volume>, no. <issue>7</issue>: <fpage>426</fpage>&#x02013;<lpage>440</lpage>.</mixed-citation></ref><ref id="cre270121-bib-0007"><mixed-citation publication-type="journal" id="cre270121-cit-0007">
<string-name>
<surname>Han</surname>, <given-names>Y. W.</given-names>
</string-name>, and <string-name>
<given-names>X.</given-names>
<surname>Wang</surname>
</string-name>. <year>2013</year>. &#x0201c;<article-title>Mobile Microbiome: Oral Bacteria in Extra&#x02010;Oral Infections and Inflammation</article-title>.&#x0201d; <source>Journal of Dental Research</source>
<volume>92</volume>, no. <issue>6</issue>: <fpage>485</fpage>&#x02013;<lpage>491</lpage>.<pub-id pub-id-type="pmid">23625375</pub-id>
</mixed-citation></ref><ref id="cre270121-bib-0008"><mixed-citation publication-type="journal" id="cre270121-cit-0008">
<string-name>
<surname>Herrera</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Sanz</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Shapira</surname>
</string-name>, et al. <year>2023</year>. &#x0201c;<article-title>Association Between Periodontal Diseases and Cardiovascular Diseases, Diabetes and Respiratory Diseases: Consensus Report of the Joint Workshop by the European Federation of Periodontology (EFP) and the European Arm of the World Organization of Family Doctors (WONCA Europe)</article-title>.&#x0201d; <source>Journal of Clinical Periodontology</source>
<volume>50</volume>, no. <issue>6</issue>: <fpage>819</fpage>&#x02013;<lpage>841</lpage>.<pub-id pub-id-type="pmid">36935200</pub-id>
</mixed-citation></ref><ref id="cre270121-bib-0009"><mixed-citation publication-type="journal" id="cre270121-cit-0009">
<string-name>
<surname>Herrera</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Sanz</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Shapira</surname>
</string-name>, et al. <year>2024</year>. &#x0201c;<article-title>Periodontal Diseases and Cardiovascular Diseases, Diabetes, and Respiratory Diseases: Summary of the Consensus Report by the European Federation of Periodontology and WONCA Europe</article-title>.&#x0201d; <source>European Journal of General Practice</source>
<volume>30</volume>, no. <issue>1</issue>: <elocation-id>2320120</elocation-id>.<pub-id pub-id-type="pmid">38511739</pub-id>
</mixed-citation></ref><ref id="cre270121-bib-0010"><mixed-citation publication-type="journal" id="cre270121-cit-0010">
<string-name>
<surname>Iqbal</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Richardson</surname>
</string-name>, <string-name>
<given-names>Z.</given-names>
<surname>Iqbal</surname>
</string-name>, et al. <year>2023</year>. &#x0201c;<article-title>Are There Socioeconomic Inequalities in Polypharmacy Among Older People? A Systematic Review and Meta&#x02010;Analysis</article-title>.&#x0201d; <source>BMC Geriatrics</source>
<volume>23</volume>, no. <issue>1</issue>: <fpage>149</fpage>.<pub-id pub-id-type="pmid">36934249</pub-id>
</mixed-citation></ref><ref id="cre270121-bib-0011"><mixed-citation publication-type="journal" id="cre270121-cit-0011">
<string-name>
<surname>Ito</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Izumi</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Funayama</surname>
</string-name>, et al. <year>2023</year>. &#x0201c;<article-title>Characteristics of Medication&#x02010;Induced Xerostomia and Effect of Treatment</article-title>.&#x0201d; <source>PLoS One</source>
<volume>18</volume>, no. <issue>1</issue>: <elocation-id>e0280224</elocation-id>.<pub-id pub-id-type="pmid">36634078</pub-id>
</mixed-citation></ref><ref id="cre270121-bib-0012"><mixed-citation publication-type="journal" id="cre270121-cit-0012">
<string-name>
<surname>Jain</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<given-names>U.</given-names>
<surname>Dutt</surname>
</string-name>, <string-name>
<given-names>I.</given-names>
<surname>Radenkov</surname>
</string-name>, and <string-name>
<given-names>S.</given-names>
<surname>Jain</surname>
</string-name>. <year>2024</year>. &#x0201c;<article-title>WHO's Global Oral Health Status Report 2022: Actions, Discussion and Implementation</article-title>.&#x0201d; <source>Oral Diseases</source>
<volume>30</volume>: <fpage>73</fpage>&#x02013;<lpage>79</lpage>. <pub-id pub-id-type="doi">10.1111/odi.14516</pub-id>.<pub-id pub-id-type="pmid">36680388</pub-id>
</mixed-citation></ref><ref id="cre270121-bib-0013"><mixed-citation publication-type="journal" id="cre270121-cit-0013">
<string-name>
<surname>Johanson</surname>, <given-names>C. N.</given-names>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>&#x000d6;sterberg</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Lernfelt</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Ekstr&#x000f6;m</surname>
</string-name>, and <string-name>
<given-names>D.</given-names>
<surname>Birkhed</surname>
</string-name>. <year>2015</year>. &#x0201c;<article-title>Salivary Secretion and Drug Treatment in Four 70&#x02010;Year&#x02010;Old Swedish Cohorts During a Period of 30 Years</article-title>.&#x0201d; <source>Gerodontology</source>
<volume>32</volume>, no. <issue>3</issue>: <fpage>202</fpage>&#x02013;<lpage>210</lpage>.<pub-id pub-id-type="pmid">26288310</pub-id>
</mixed-citation></ref><ref id="cre270121-bib-0014"><mixed-citation publication-type="journal" id="cre270121-cit-0014">
<string-name>
<surname>Knorst</surname>, <given-names>J. K.</given-names>
</string-name>, <string-name>
<given-names>C. S.</given-names>
<surname>Sfreddo</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>de F. Meira</surname>
</string-name>, <string-name>
<given-names>F. B.</given-names>
<surname>Zanatta</surname>
</string-name>, <string-name>
<given-names>M. V.</given-names>
<surname>Vettore</surname>
</string-name>, and <string-name>
<given-names>T. M.</given-names>
<surname>Ardenghi</surname>
</string-name>. <year>2021</year>. &#x0201c;<article-title>Socioeconomic Status and Oral Health&#x02010;Related Quality of Life: A Systematic Review and Meta&#x02010;Analysis</article-title>.&#x0201d; <source>Community Dentistry and Oral Epidemiology</source>
<volume>49</volume>, no. <issue>2</issue>: <fpage>95</fpage>&#x02013;<lpage>102</lpage>.<pub-id pub-id-type="pmid">33368600</pub-id>
</mixed-citation></ref><ref id="cre270121-bib-0015"><mixed-citation publication-type="journal" id="cre270121-cit-0015">
<string-name>
<surname>Larvin</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Kang</surname>
</string-name>, <string-name>
<given-names>V. R.</given-names>
<surname>Aggarwal</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Pavitt</surname>
</string-name>, and <string-name>
<given-names>J.</given-names>
<surname>Wu</surname>
</string-name>. <year>2023</year>. &#x0201c;<article-title>Periodontitis and Risk of Immune&#x02010;Mediated Systemic Conditions: A Systematic Review and Meta&#x02010;Analysis</article-title>.&#x0201d; <source>Community Dentistry and Oral Epidemiology</source>
<volume>51</volume>, no. <issue>5</issue>: <fpage>705</fpage>&#x02013;<lpage>717</lpage>.<pub-id pub-id-type="pmid">36377800</pub-id>
</mixed-citation></ref><ref id="cre270121-bib-0016"><mixed-citation publication-type="journal" id="cre270121-cit-0016">
<string-name>
<surname>Liccardo</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Cannavo</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Spagnuolo</surname>
</string-name>, et al. <year>2019</year>. &#x0201c;<article-title>Periodontal Disease: A Risk Factor for Diabetes and Cardiovascular Disease</article-title>.&#x0201d; <source>International Journal of Molecular Sciences</source>
<volume>20</volume>, no. <issue>6</issue>: <fpage>1414</fpage>.<pub-id pub-id-type="pmid">30897827</pub-id>
</mixed-citation></ref><ref id="cre270121-bib-0017"><mixed-citation publication-type="journal" id="cre270121-cit-0017">
<string-name>
<surname>Makovski</surname>, <given-names>T. T.</given-names>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Schmitz</surname>
</string-name>, <string-name>
<given-names>M. P.</given-names>
<surname>Zeegers</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Stranges</surname>
</string-name>, and <string-name>
<given-names>M.</given-names>
<surname>van den Akker</surname>
</string-name>. <year>2019</year>. &#x0201c;<article-title>Multimorbidity and Quality of Life: Systematic Literature Review and Meta&#x02010;Analysis</article-title>.&#x0201d; <source>Ageing Research Reviews</source>
<volume>53</volume>: <elocation-id>100903</elocation-id>.<pub-id pub-id-type="pmid">31048032</pub-id>
</mixed-citation></ref><ref id="cre270121-bib-0018"><mixed-citation publication-type="journal" id="cre270121-cit-0018">
<string-name>
<surname>Masnoon</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Shakib</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Kalisch&#x02010;Ellett</surname>
</string-name>, and <string-name>
<given-names>G. E.</given-names>
<surname>Caughey</surname>
</string-name>. <year>2017</year>. &#x0201c;<article-title>What Is Polypharmacy? A Systematic Review of Definitions</article-title>.&#x0201d; <source>BMC Geriatrics</source>
<volume>17</volume>, no. <issue>1</issue>: <fpage>230</fpage>.<pub-id pub-id-type="pmid">29017448</pub-id>
</mixed-citation></ref><ref id="cre270121-bib-0019"><mixed-citation publication-type="journal" id="cre270121-cit-0019">
<string-name>
<surname>Mattila</surname>, <given-names>P. T.</given-names>
</string-name>, <string-name>
<given-names>M. C.</given-names>
<surname>Niskanen</surname>
</string-name>, <string-name>
<given-names>M. M.</given-names>
<surname>Vehkalahti</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Nordblad</surname>
</string-name>, and <string-name>
<given-names>M. L. E.</given-names>
<surname>Knuuttila</surname>
</string-name>. <year>2010</year>. &#x0201c;<article-title>Prevalence and Simultaneous Occurrence of Periodontitis and Dental Caries</article-title>.&#x0201d; <source>Journal of Clinical Periodontology</source>
<volume>37</volume>, no. <issue>11</issue>: <fpage>962</fpage>&#x02013;<lpage>967</lpage>.<pub-id pub-id-type="pmid">20958340</pub-id>
</mixed-citation></ref><ref id="cre270121-bib-0020"><mixed-citation publication-type="journal" id="cre270121-cit-0020">
<string-name>
<surname>Meurman</surname>, <given-names>J. H.</given-names>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Rajasuo</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Murtomaa</surname>
</string-name>, and <string-name>
<given-names>S.</given-names>
<surname>Savolainen</surname>
</string-name>. <year>1995</year>. &#x0201c;<article-title>Respiratory Tract Infections and Concomitant Pericoronitis of the Wisdom Teeth</article-title>.&#x0201d; <source>BMJ</source>
<volume>310</volume>, no. <issue>6983</issue>: <fpage>834</fpage>&#x02013;<lpage>836</lpage>.<pub-id pub-id-type="pmid">7711620</pub-id>
</mixed-citation></ref><ref id="cre270121-bib-0021"><mixed-citation publication-type="journal" id="cre270121-cit-0021">
<string-name>
<surname>Moreira</surname>, <given-names>L. V.</given-names>
</string-name>, <string-name>
<given-names>E. L.</given-names>
<surname>Galv&#x000e3;o</surname>
</string-name>, <string-name>
<given-names>P. S.</given-names>
<surname>Mour&#x000e3;o</surname>
</string-name>, <string-name>
<given-names>M. L.</given-names>
<surname>Ramos&#x02010;Jorge</surname>
</string-name>, and <string-name>
<given-names>I. B.</given-names>
<surname>Fernandes</surname>
</string-name>. <year>2023</year>. &#x0201c;<article-title>Association Between Asthma and Oral Conditions in Children and Adolescents: A Systematic Review With Meta&#x02010;Analysis</article-title>.&#x0201d; <source>Clinical Oral Investigations</source>
<volume>27</volume>, no. <issue>1</issue>: <fpage>45</fpage>&#x02013;<lpage>67</lpage>.<pub-id pub-id-type="pmid">36459238</pub-id>
</mixed-citation></ref><ref id="cre270121-bib-0022"><mixed-citation publication-type="journal" id="cre270121-cit-0022">
<string-name>
<surname>Noites</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Teixeira</surname>
</string-name>, <string-name>
<given-names>I.</given-names>
<surname>Cavero&#x02010;Redondo</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Alvarez&#x02010;Bueno</surname>
</string-name>, and <string-name>
<given-names>F.</given-names>
<surname>Ribeiro</surname>
</string-name>. <year>2022</year>. &#x0201c;<article-title>Apical Periodontitis and Cardiovascular Disease in Adults: A Systematic Review With Meta&#x02010;Analysis</article-title>.&#x0201d; <source>Reviews in Cardiovascular Medicine</source>
<volume>23</volume>, no. <issue>3</issue>: <fpage>100</fpage>.<pub-id pub-id-type="pmid">35345267</pub-id>
</mixed-citation></ref><ref id="cre270121-bib-0023"><mixed-citation publication-type="journal" id="cre270121-cit-0023">
<string-name>
<surname>Schenkein</surname>, <given-names>H. A.</given-names>
</string-name>, <string-name>
<given-names>P. N.</given-names>
<surname>Papapanou</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Genco</surname>
</string-name>, and <string-name>
<given-names>M.</given-names>
<surname>Sanz</surname>
</string-name>. <year>2020</year>. &#x0201c;<article-title>Mechanisms Underlying the Association Between Periodontitis and Atherosclerotic Disease</article-title>.&#x0201d; <source>Periodontology 2000</source>
<volume>83</volume>, no. <issue>1</issue>: <fpage>90</fpage>&#x02013;<lpage>106</lpage>.<pub-id pub-id-type="pmid">32385879</pub-id>
</mixed-citation></ref><ref id="cre270121-bib-0024"><mixed-citation publication-type="journal" id="cre270121-cit-0024">
<string-name>
<surname>Sebring</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Buhlin</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Norhammar</surname>
</string-name>, et al. <year>2022</year>. &#x0201c;<article-title>Endodontic Inflammatory Disease: A Risk Indicator for a First Myocardial Infarction</article-title>.&#x0201d; <source>International Endodontic Journal</source>
<volume>55</volume>, no. <issue>1</issue>: <fpage>6</fpage>&#x02013;<lpage>17</lpage>.<pub-id pub-id-type="pmid">34561889</pub-id>
</mixed-citation></ref><ref id="cre270121-bib-0025"><mixed-citation publication-type="journal" id="cre270121-cit-0025">
<string-name>
<surname>Smidt</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<given-names>L. A.</given-names>
<surname>Torpet</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Nauntofte</surname>
</string-name>, <string-name>
<given-names>K. M.</given-names>
<surname>Heegaard</surname>
</string-name>, and <string-name>
<given-names>A. M. L.</given-names>
<surname>Pedersen</surname>
</string-name>. <year>2010</year>. &#x0201c;<article-title>Associations Between Labial and Whole Salivary Flow Rates, Systemic Diseases and Medications in a Sample of Older People</article-title>.&#x0201d; <source>Community Dentistry and Oral Epidemiology</source>
<volume>38</volume>, no. <issue>5</issue>: <fpage>422</fpage>&#x02013;<lpage>435</lpage>.<pub-id pub-id-type="pmid">20545715</pub-id>
</mixed-citation></ref><ref id="cre270121-bib-0026"><mixed-citation publication-type="journal" id="cre270121-cit-0026">
<string-name>
<surname>Smidt</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<given-names>L. A.</given-names>
<surname>Torpet</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Nauntofte</surname>
</string-name>, <string-name>
<given-names>K. M.</given-names>
<surname>Heegaard</surname>
</string-name>, and <string-name>
<given-names>A. M. L.</given-names>
<surname>Pedersen</surname>
</string-name>. <year>2011</year>. &#x0201c;<article-title>Associations Between Oral and Ocular Dryness, Labial and Whole Salivary Flow Rates, Systemic Diseases and Medications in a Sample of Older People</article-title>.&#x0201d; <source>Community Dentistry and Oral Epidemiology</source>
<volume>39</volume>, no. <issue>3</issue>: <fpage>276</fpage>&#x02013;<lpage>288</lpage>.<pub-id pub-id-type="pmid">21070322</pub-id>
</mixed-citation></ref><ref id="cre270121-bib-0027"><mixed-citation publication-type="journal" id="cre270121-cit-0027">
<string-name>
<surname>S&#x000f6;der</surname>, <given-names>P. &#x000d6;.</given-names>
</string-name>, <string-name>
<given-names>L. J.</given-names>
<surname>Jin</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>S&#x000f6;der</surname>
</string-name>, and <string-name>
<given-names>S.</given-names>
<surname>Wikner</surname>
</string-name>. <year>1994</year>. &#x0201c;<article-title>Periodontal Status in an Urban Adult Population in Sweden</article-title>.&#x0201d; <source>Community Dentistry and Oral Epidemiology</source>
<volume>22</volume>, no. <issue>2</issue>: <fpage>106</fpage>&#x02013;<lpage>111</lpage>.<pub-id pub-id-type="pmid">8205774</pub-id>
</mixed-citation></ref><ref id="cre270121-bib-0028"><mixed-citation publication-type="journal" id="cre270121-cit-0028">
<string-name>
<surname>Stangvaltaite&#x02010;Mouhat</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Skudutyte&#x02010;Rysstad</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Ko</surname>
</string-name>, <string-name>
<given-names>I.</given-names>
<surname>Stankeviciene</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Aleksejuniene</surname>
</string-name>, and <string-name>
<given-names>A.</given-names>
<surname>Puriene</surname>
</string-name>. <year>2024</year>. &#x0201c;<article-title>Co&#x02010;Occurrence of Dental Caries and Periodontitis: Multilevel Modelling Approach</article-title>.&#x0201d; <source>BMC Oral Health</source>
<volume>24</volume>, no. <issue>1</issue>: <fpage>149</fpage>.<pub-id pub-id-type="pmid">38297235</pub-id>
</mixed-citation></ref><ref id="cre270121-bib-0029"><mixed-citation publication-type="journal" id="cre270121-cit-0029">
<string-name>
<surname>Tavares</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<given-names>K. A.</given-names>
<surname>Lindefjeld Calabi</surname>
</string-name>, and <string-name>
<given-names>L.</given-names>
<surname>San Martin</surname>
</string-name>. <year>2014</year>. &#x0201c;<article-title>Systemic Diseases and Oral Health</article-title>.&#x0201d; <source>Dental Clinics of North America</source>
<volume>58</volume>, no. <issue>4</issue>: <fpage>797</fpage>&#x02013;<lpage>814</lpage>.<pub-id pub-id-type="pmid">25201543</pub-id>
</mixed-citation></ref><ref id="cre270121-bib-0030"><mixed-citation publication-type="journal" id="cre270121-cit-0030">
<string-name>
<surname>Teles</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<given-names>R. G.</given-names>
<surname>Collman</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Mominkhan</surname>
</string-name>, and <string-name>
<given-names>Y.</given-names>
<surname>Wang</surname>
</string-name>. <year>2022</year>. &#x0201c;<article-title>Viruses, Periodontitis, and Comorbidities</article-title>.&#x0201d; <source>Periodontology 2000</source>
<volume>89</volume>, no. <issue>1</issue>: <fpage>190</fpage>&#x02013;<lpage>206</lpage>.<pub-id pub-id-type="pmid">35244970</pub-id>
</mixed-citation></ref><ref id="cre270121-bib-0031"><mixed-citation publication-type="journal" id="cre270121-cit-0031">
<string-name>
<surname>Thomas</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Parolia</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Kundabala</surname>
</string-name>, and <string-name>
<given-names>M.</given-names>
<surname>Vikram</surname>
</string-name>. <year>2010</year>. &#x0201c;<article-title>Asthma and Oral Health: A Review</article-title>.&#x0201d; <source>Australian Dental Journal</source>
<volume>55</volume>, no. <issue>2</issue>: <fpage>128</fpage>&#x02013;<lpage>133</lpage>.<pub-id pub-id-type="pmid">20604752</pub-id>
</mixed-citation></ref><ref id="cre270121-bib-0032"><mixed-citation publication-type="journal" id="cre270121-cit-0032">
<string-name>
<surname>Tooth</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Hockey</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Byles</surname>
</string-name>, and <string-name>
<given-names>A.</given-names>
<surname>Dobson</surname>
</string-name>. <year>2008</year>. &#x0201c;<article-title>Weighted Multimorbidity Indexes Predicted Mortality, Health Service Use, and Health&#x02010;Related Quality of Life in Older Women</article-title>.&#x0201d; <source>Journal of Clinical Epidemiology</source>
<volume>61</volume>, no. <issue>2</issue>: <fpage>151</fpage>&#x02013;<lpage>159</lpage>.<pub-id pub-id-type="pmid">18177788</pub-id>
</mixed-citation></ref><ref id="cre270121-bib-0033"><mixed-citation publication-type="journal" id="cre270121-cit-0033">
<string-name>
<surname>Turner</surname>, <given-names>M. D.</given-names>
</string-name>
<year>2016</year>. &#x0201c;<article-title>Hyposalivation and Xerostomia</article-title>.&#x0201d; <source>Dental Clinics of North America</source>
<volume>60</volume>, no. <issue>2</issue>: <fpage>435</fpage>&#x02013;<lpage>443</lpage>.<pub-id pub-id-type="pmid">27040294</pub-id>
</mixed-citation></ref><ref id="cre270121-bib-0034"><mixed-citation publication-type="journal" id="cre270121-cit-0034">
<string-name>
<surname>Villa</surname>, <given-names>A.</given-names>
</string-name>, and <string-name>
<given-names>S.</given-names>
<surname>Abati</surname>
</string-name>. <year>2011</year>. &#x0201c;<article-title>Risk Factors and Symptoms Associated With Xerostomia: A Cross&#x02010;Sectional Study</article-title>.&#x0201d; <source>Australian Dental Journal</source>
<volume>56</volume>, no. <issue>3</issue>: <fpage>290</fpage>&#x02013;<lpage>295</lpage>.<pub-id pub-id-type="pmid">21884145</pub-id>
</mixed-citation></ref><ref id="cre270121-bib-0035"><mixed-citation publication-type="journal" id="cre270121-cit-0035">
<string-name>
<surname>Villa</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Wolff</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Narayana</surname>
</string-name>, et al. <year>2016</year>. &#x0201c;<article-title>World Workshop on Oral Medicine VI: A Systematic Review of Medication&#x02010;Induced Salivary Gland Dysfunction</article-title>.&#x0201d; <source>Oral Diseases</source>
<volume>22</volume>, no. <issue>5</issue>: <fpage>365</fpage>&#x02013;<lpage>382</lpage>.<pub-id pub-id-type="pmid">26602059</pub-id>
</mixed-citation></ref><ref id="cre270121-bib-0036"><mixed-citation publication-type="miscellaneous" id="cre270121-cit-0036">
<collab collab-type="authors">WHO</collab>
. <article-title>Global Age&#x02010;Friendly Cities Project</article-title>. <year>2007</year>.</mixed-citation></ref><ref id="cre270121-bib-0037"><mixed-citation publication-type="journal" id="cre270121-cit-0037">
<string-name>
<surname>Wiriyakijja</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<given-names>S. E.</given-names>
<surname>Niklander</surname>
</string-name>, <string-name>
<given-names>A. R.</given-names>
<surname>Santos&#x02010;Silva</surname>
</string-name>, et al. <year>2023</year>. &#x0201c;<article-title>World Workshop on Oral Medicine VIII: Development of a Core Outcome Set for Dry Mouth: A Systematic Review of Outcome Domains for Xerostomia</article-title>.&#x0201d; <source>Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology</source>
<volume>135</volume>, no. <issue>6</issue>: <fpage>827</fpage>&#x02013;<lpage>875</lpage>.<pub-id pub-id-type="pmid">37198047</pub-id>
</mixed-citation></ref></ref-list></back></article>